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ABSTRACT OF DISSERTATION

COOPERATIVE AND ANTAGONISTIC ROLES FOR HETEROCHROMATIN PROTEINS IN
TRANSCRIPTIONAL REGULATION OF THE DROSOPHILA SEX DETERMINATION
MASTERSWITCH GENE
HOAP was originally identified as a component of an ORC-containing multi-protein
complex of Heterochromatin Protein 1 (HP1) from early Drosophila embryos. HOAP
immunostaining showed prominent association of it with telomeres, and mutants for HOAP
(cav1) showed it functions along with HP1 in forming a telomere capping complex that prevents
telomeric fusions.
Weaker HOAP immunostaining is also observed in regions of pericentric heterochromatin
and euchromatin. To examine the role of HOAP at these non-telomeric sites, we applied
Affymetric Drosophila Genome Arrays to undertake a microarray expression profiling study of
genes that are mis-expressed in cav1 mutant larvae. The data from four publicly available
databases were used to assess the normal expression patterns of the affected genes. We found that
the majority (67%) of genes with decreased expression levels in cav1 mutants (log2R< -2.0, pvalue≤
0.01) have normally testis-specific expression. These results could indicate a role of HOAP in
testis-specific gene expression. Alternatively they could reflect reduced male viability due to the
loss of HOAP, which resulted in the under-representation of males in the cav1 larval sample. The
latter hypothesis is supported by the observation of 2.8-fold under-representation of males in cav1
larvae when I used a yellow+-marked X chromosome to differentially mark male and female cav1
larvae. Thus, this project is focused on determining and characterizing the cause of the reduced
male viability.
Here I report a role for both HOAP and HP1 in regulating the establishment promoter, SxlPe,
of the sex determination masterswitch, Sex lethal (Sxl). Female-specific activation of SxlPe is
essential to females as it provides SXL protein to initiate productive female-specific splicing of
the late Sxl transcripts which are transcribed in both sexes. We find inappropriate firing of SxlPe
and splicing of Sxl transcripts in male cav mutants, whereas mutants for HP1 display Sxl splicing
defects in both sexes. Both proteins are associated with SxlPe sequences. In embryos from HP1
mothers and Sxl mutant fathers, female viability and RNA polymerase II recruitment to SxlPe is
severely compromised. Our genetic and biochemical assays suggest a repressing activity for
HOAP and both activating and repressing roles for HP1 at SxlPe.
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Chapter One
Background

Euchromatin and heterochromatin
Eukaryotic chromosomes are composed of DNA, which is wrapped around histones, and
associated with a variety of non-histone proteins to form visible thread-like structures within each
nucleus. The DNA/protein complexes, called chromatin, fall into two major classes: euchromatin
and heterochromatin (Heitz, 1928). Historically, this classification is based on their differential
staining properties in the interphase nucleus and reflects different molecular compositions.
Euchromatin is loosely packed and weakly staining during interphase, whereas heterochromatin
remains tightly packed and deeply staining throughout the cell cycle (Heitz, 1928).
Heterochromatin and euchromatin also have different functional properties. Ris and Korenberg
(Ris and Korenberg, 1979) showed that heterochromatin has low levels of transcription. These
low transcription levels may be related to its location next to the nuclear envelope, as Andrulis et
al. (Andrulis et al., 1998) showed that reporter genes are silenced when targeted to the nuclear
periphery. The different properties of heterochromatin also include their DNA replication and
recombination activities. Lima-de-Faria and Jaworska (Lima-de-Faria and Jaworska, 1968) used
tritiated thymidine ([3H]TdR) labeling to monitor chromosome replication patterns and concluded
that heterochromatin is synthesized later in S phase than euchromatin. Natarajan and Gropp
(Natarajan and Gropp, 1971) showed the absence of chiasmata in homologously paired regions of
heterochromatin during meiosis, possibly accounting for the minimal recombination observed in
heterochromatin. Yet heterochromatin was later shown to be required for homologous
chromosome pairing and proper disjunction (Dernburg et al., 1996). Cohesin proteins, which are
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essential for proper chromosome segregation, are also dependent on Heterochromatin Protein 1
(HP1) for their recruitment to peri-centric regions (Nonaka et al., 2002).
The different functional properties of heterochromatin and euchromatin, described above,
correlate with their distinct structures. The more compact structure of heterochromatin, compared
to euchromatin, is established and maintained through various epigenetic mechanisms which
produce heritable changes in gene expression that do not involve mutations in the sequence of the
gene itself (the Greek word “epi” means “over” or “above”). These mechanisms involve noncoding RNA molecules, histone modifications and, in some species, DNA methylation. Covalent
modifications on histone N-terminal tails (acetylation, methylation, phosphorylation etc.,) alter
the chromatin structure by interacting with specific non-histone proteins to make chromatin more
or less compact (Strahl and Allis, 2000). Some of these histone modifications are responsible for
recruiting heterochromatin specific non-histone proteins. For example, SU(VAR)3-9 which is a
histone H3 lysine 9-specific methyltransferase, converts monomethyl H3K9 into the dimethylated
form, and dimethyl to trimethl H3K9, to provide binding-sites for HP1 at heterochromatic loci
(James et al., 1989; Tschiersch et al., 1994).
In the fission yeast Schizosaccharomyces pombe, the recruitment of the SU(VAR)3-9 homolog
(Clr4) and Swi6 (HP1 homolog) to centromeric heterochromatin was shown to be mediated by
the RNAi machinery (Volpe et al., 2002). In Drosophila, Elgin and co-workers showed that
small RNAs, produced by the RNAi machinery from the most abundant transposable element
1360, are required for HP1-dependent silencing of an adjacent reporter gene in pericentric
heterochromatin (Haynes et al., 2006). RNAi-independent mechanisms, involving DNA-binding
proteins, were also shown to operate in the heterochromatin of centromeres and the mating type
loci of S. pombe (Jia et al., 2004; Nakagawa et al., 2002). HP1 recruitment to pericentric
heterochromatin was proposed to occur through the DNA-binding activities of HOAP

2

(HP1/ORC-Associated Protein) and ORC (Origin Recognition Complex) proteins in Drosphila
(Shareef et al., 2003).
Heterochromatin can be further categorized into constitutive and facultative types. Constitutive
heterochromatin retains its heterochromatic properties in all cell types of a given species. It is
mainly found in pericentric and telomeric regions, which are enriched with transposons and noncoding, repetitive DNA (Cooper, 1959; Goodfellow et al., 1985; Hannah, 1951). K9-methylated
histone H3 and HP1 are two conserved markers for constitutive heterochromatin. Although it
shares the compact features of constitutive heterochromatin, facultative heterochromatin (the latin
word “facultas” means “opportunity”) has the opportunity to take on either the looser
conformation of euchromatin or the more compact conformation of heterochromatin in specific
cell types. A gene contained within facultative heterochromatin in one cell type, where it is
silenced, may be packaged into euchromatin and expressed in another cell type. A classic
example of facultative heterochromatin is the inactive X-chromosome in mammalian females
(Chow and Brown, 2003), in which one of its two X chromosomes is randomly chosen to adopt a
state of facultative heterochromatin and remain silent, while the other is packaged into
euchromatin and capable of being expressed. Facultative heterochromatin is marked by lysine
27- methylated histone H3 (MeK27H3, which is recognized by the Polycomb protein (Fischle et
al., 2003), the founding member of PcG repressor proteins, which shares the chromodomain
homology with HP1. The chromodomain allows chromodomain proteins to bind methylated
histone H3, although with slightly different specificities (Nielsen et al., 2001).

Position Effect Variegation (PEV) assay
The classic epigenetic phenomenon, Position Effect Variegation (PEV), first described by Muller
in 1930 (Muller, 1930), has been applied to identify non-histone chromosomal proteins which
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affect euchromatic gene expression by altering chromosome structure. PEV occurs when
euchromatic genes are placed next to heterochromatin by a chromosomal rearrangement, causing
the mosaic inactivation of these genes through random spreading of heterochromatin over them;
once inactivated, the silent state is maintained during cell divisions to produce the variegated
phenotype (Weiler and Wakimoto, 1995). This position effect on the expression of euchromatic
genes can be suppressed by dominant mutations in genes encoding trans-acting proteins involved
in heterochromatin assembly. This phenomenon prompted multiple genetic screens to identify a
large number of Suppressor of variegation [Su(var)] genes encoding proteins that function in the
assembly or maintenance of heterochromatin, including the Su(var)205 gene for the first
identified heterochromatin protein, HP1, as well as the gene for the SU(VAR)3-9 enzyme
responsible for lysine 9-specific methylation of histone H3 (James et al., 1989; Tschiersch et al.,
1994). HP1 was first discovered in Drosophila and is a highly conserved heterochromatin
component in species ranging from fission yeast to humans. However, HP1 is also recruited to
euchromatic regions (for example, cytological region 31 in Drosophila) and has been found to
have a positive role in the expression of some genes in this region (Cryderman et al., 2005;
Piacentini et al., 2003).

Identification of HP1-ORC Associated Protein (HOAP)
Because early studies failed to demonstrate DNA binding activity for HP1, its incorporation into
heterochromatin was proposed to involve DNA-binding proteins. A biochemical approach was
used by previous members of the lab (Huang et al., 1998; Pak et al., 1997) to characterize HP1
complexes from early Drosophila embryos in search of these proteins. In these studies, HP1 was
found to exist in three different protein complexes in the cytoplasm from early Drosophila
embryos. The smallest of these contained HP1 alone, whereas the two larger ones contained
Origin Recognition Complex (ORC) subunits 2, 5 and 6 and hypo-phosphorylated HP1. A novel
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55-kDa protein was also observed in the Coomassie-stained profiles of the two larger complexes
(Figure 1.1) and was subjected to Edman degradation to determine its identity. Its peptide
sequence matched the hypothetical protein-coding sequence of the anon fe 1G5 gene from
Drosophila melanogaster, a gene that had been identified in a molecular screen for fast-evolving
genes in Drosophila species (Schmid and Tautz, 1997). Antibody raised against the protein
product of the gene recognized p55 in the HP1 complexes and was found to coimmunoprecipitate HP1 and ORC subunits in a reciprocal immunoprecipitation experiment
(Huang et al., 1998; Shareef et al., 2003). The anon fe 1G5 gene product, therefore, was renamed
HP1/ORC-Associated Protein (HOAP). The N-terminus of HOAP contains sequence similarity
to the HMG box DNA binding motif of the mammalian Sex-determining Region of the Y (SRY)
proteins (24% identity and 40% similarity), and a recombinant HOAP protein was shown to bind
specific Drosophila satellite and a Drosophila telomere-associated sequence (TAS) in vitro
(Shareef et al., 2001).

The DNA-binding activities of HOAP and ORC led the lab to propose a role for them in targeting
HP1 to heterochromatin (Shareef et al., 2001). Supporting this model, mutants for ORC2
exhibited reduced HP1 immunostaining in pericentric heterochromatin of diploid nuclei, and
mutations in either ORC2 or HOAP suppress PEV (Huang et al., 1998). HOAP immunostaining
showed prominent association of it with telomeres; weaker immunostaining was also observed in
regions of pericentric heterochromatin and euchromatin (Figure 1.2). The partial overlap between
the immunostaining patterns for HOAP and HP1 suggested a more specialized function for
HOAP in heterochromatin, perhaps in targeting HP1 to heterochromatin nucleation sites. The Cterminus of HOAP contains three novel PETEMNE peptide motifs (Figure 1.1), which were
shown to be responsible for binding HP1 through HP1 chromo shadow domain and hinge domain
(Badugu et al., 2003; Badugu et al., 2005). Interestingly, incubation of salivary glands with

5

PETEMNE peptide or di-MeK9H3 peptide causes release of HP1 from pericentric
heterochromatin (Badugu et al., 2003).

HOAP at telomeres
The ends of linear eukaryotic chromosomes, called telomeres (the Greek word “telos” means
“end”, and “mere” means “part”), have a heterochromatic structure which protects chromosomes
from undergoing end-to-end fusion or degradation. Telomeres of most eukaryotes are composed
of tandem repeats of short sequences (e.g. TTAGGG repeats), which are generated by an RNAtemplated DNA polymerase enzyme called telomerase (Greider and Blackburn, 1985). The
extreme end of telomeres is protected by its surrounding proteins to be distinguished by cells
from broken ends. In most human cells, this includes the POT1 (protection of telomere 1)
polypeptide that binds to 3’-overhang (Baumann and Cech, 2001; Baumann et al., 2002), TRF1
and TRF2 (telomeric repeat binding factor 1 and 2) proteins that directly bind to TTAGGG
duplex (Broccoli et al., 1997; van Steensel et al., 1998) and TRF2-interacting Ku70/80 proteins
that are also essential for DNA repair (Song et al., 2000).

Drosophila does not have a gene for telomerase. Rather, the RNA-templated DNA polymerase
activity of a reverse transcriptase (RT) is encoded in the telomeric DNA itself (Pardue et al.,
1996), which consists of an array of non-long-terminal-repeat (non-LTR) retrotransposons (HetA, TART and TAHRE). TART and TAHRE elements contain RT-coding sequence (Abad et al.,
2004; Mason and Biessmann, 1995; Pardue et al., 1996). In Drosophila, HP1 and HOAP form a
telomere-capping complex to protect telomeres (Cenci et al., 2003). Loss-of-function mutations
in the HOAP-encoding gene caravaggio (cav) were identified on the basis of their telomeretelomere fusion phenotype (Cenci et al., 2003). Mutants for HP1 had been shown earlier to have
a telomere fusion phenotype (Fanti et al., 1998). The cav1 mutant identified in the Cenci et al.
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study (Cenci et al., 2003) expresses a HOAP protein that lacks the third HP1-interacting
PETEMNE motif in its C-terminus. Mitotic chromosomes in larval brains from this cav1 mutant
lack HOAP immunostaining at telomeres. The HP1 telomeric signals were unable to be analyzed
in mitotic chromosomes from cav1 mutants, due to dispersion of HP1 from chromosomes during
mitosis (Kellum et al., 1995). However, both HOAP and HP1 signals were lost at telomeres of
polytene chromosomes from the cav1 mutant, in spite of the fact that polytene chromosomes do
not undergo telomeric fusions (unpublished data). The HOAP signals were still present in a
minor fraction of mitotic chromosomes in Su(var)205 mutants that displayed telomere fusions,
indicating that HOAP can bind to telomeres in an HP1-independent manner. Cenci et al. (Cenci
et al., 2003) also showed that HOAP can bind telomeres lacking all telomere-associated
sequences. A recently discovered HipHop protein interacts with HP1/HOAP telomere capping
complex, and its binding to telomeres is also independent of specific telomeric sequences (Gao et
al., 2010). Binding of both HOAP and HP1 to telomeres is dependent upon a telomere
maintenance mechanism mediated by the ATM (ataxia telangiectasia mutated) and ATR (ATM
and Rad3-related) checkpoint kinases, presumably by processing the DNA to provide a specific
secondary structural feature needed for HOAP/HP1 binding (Bi et al., 2005). The transcription
factor WOC is also required for telomere-capping through a mechanism that does not involve
either HOAP, HP1, or ATM/ATR (Raffa et al., 2005).

HP1 has a second function at telomeres in repressing the transcription of telomeric transposons
through its association with MeK9H3. Recruitment of MeK9H3 to telomeres does not involve
the RNAi machinery in the soma, but does involve it in the germline (Perrini et al., 2004;
Savitsky, 2006; Shpiz et al., 2007). ORC also does not appear to be enriched in telomeres or
required to prevent telomere fusions (Cenci et al., 2003).
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HOAP in 3L pericentric heterochromatin
A previous member of the Kellum lab (Rama Badugu, unpublished data) used a direct approach,
chromatin immunoprecipitation (ChIP) on chip experiments, to identify HOAP-binding DNA
sequences in a region of 3L heterochromatin where HOAP immunostaining was consistently
observed (Figure 1.2) (Shareef et al., 2001). For this study, a custom microarray containing 45bp
oligonucleotides spanning 525kb of non-repetitive DNA from this region was made. The results
of this study are shown in Figure 1.3. HOAP was found to be enriched at least two fold in the
ChIP sample relative to the input sample at nine sites within this region. Four of these sites were
associated with regions flanking transposable elements (blue stars) and five were associated with
regions flanking unique gene coding sequences (red stars). Among twenty three genes included
in this genomic region, only five were associated with HOAP and four of these were testisspecific (CG11226, CG32462, CG32459, and CG32461, shown in red letters), as assessed
through cDNA representation data and microarray expression profiling data (Chintapalli et al.,
2007; Parisi et al., 2004). The fifth gene, CG11131, is expressed specifically in the male
accessory gonad.

HOAP in euchromatin
Weaker HOAP immunostaining is also observed at numerous sites distributed throughout the
euchromatic arms of polytene chromosomes (Figure 1.2). Affymetrix Drosophila Genome
microarrays were used by Momin Shareef in an expression profiling study to identify genes that
are mis-regulated in the cav1 mutant, as candidate HOAP-regulated genes, before I joined the lab.
The expression profile of the cav1 mutant was compared to that of wild type animals at the first
and second instar larval stage, prior to the lethal phase for the cav1 mutant (Cenci et al., 2003).
Out of 13,500 transcription units represented on this array, 183 genes were found to have
significantly altered expression (log2R> +2.0 or log2R< -2.0, p< 0.01) in cav1 mutant larvae.
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Within this set, 142 genes had decreased transcript levels and 41 genes had increased levels in the
cav1 mutant (Table 1.1).

We used four publicly available databases to catalogue the normal expression profiles of genes in
each data set. A gene’s relative representation in publicly available tissue-specific cDNA
libraries (Andrews et al., 2000; Stapleton et al., 2002) provided the first method for assessing its
normal expression. This analysis was complemented by data from other published microarray
profiling studies of sex- or tissue-specific gene expression in Drosophila melanogaster
(Arbeitman et al., 2002; Chintapalli et al., 2007; Parisi et al., 2004). Six groups were used to
categorize the genes with decreased transcript levels in the cav1 mutant (Multiple, Rare, Embryo,
Ovary, Testis and Testis & Ovary), as summarized in Table 1.1. Four groups were used to
classify the genes with increased transcript levels (Carcass, Midgut, Multiple and Rare). Genes
categorized as “Multiple” were represented in cDNA libraries of multiple developmental
specificities and expressed at high levels in multiple adult tissues (Chintapalli et al., 2007).
Genes categorized as “Rare” were represented by a single of few cDNA clones, usually one
generated from a mixed pools of RNA of various developmental specificities, and were detected
at low levels in all or multiple tissues. Those categorized as specific for a given tissue (e.g. testis)
were predominantly or only represented in cDNA libraries of that specificity and were enriched
specifically in that tissue in the tissue-specific expression profiling studies of Chintapalli et al.
and Parisi et al. (Chintapalli et al., 2007; Parisi et al., 2004). The most striking pattern to emerge
from these analyses was the abundance of testis-specific genes (67%) in the set of genes with
decreased transcript levels in cav1 mutant. This is in contrast to only 12% of Drosophila
melanogaster genes normally being testis-specific (Boutanaev et al., 2002; Parisi et al., 2004).
No testis-enriched genes were found in the set of genes with increased transcript levels in the cav1
mutant.
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The results of the cav1 expression profiling study could be interpreted in three possible ways. The
direct interpretation is that HOAP is required for expression of these testis-specific genes. An
alternative interpretation is that HOAP is required for male viability, and the decreased level of
testis-specific transcripts in the cav1 mutant results from under-representation of males in the
larvae used to extract RNA. The last interpretation is that HOAP is required for both: for
expression of testis-specific genes and for some male-specific genes needed for male viability.
The second possibility was supported by several studies showing males are more sensitive to loss
of heterochromatin proteins (Liu et al., 2005; Spierer et al., 2005). Sun and co-workers, (Liu et
al., 2005; Spierer et al., 2005) used the UAS/GAL4 binary system to drive the expression of a
UAS-driven transgene for HP1 interference RNA to knock down HP1 levels and observed
enhanced lethality for adult males. A similar phenotype was also observed for mutants for the
HP1-interacting proteins, SU(VAR)3-7 (Spierer et al., 2005) and Drosophila TIF1β (bonus)
(Beckstead et al., 2005). Because of these findings, the first goal of my project was to determine
whether mutants for HOAP have reduced male viability, and if so, to characterize the cause of
this reduced viability.

Copyright © Hui Li 2011
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Figure 1.1. HOAP (HP1/ORC-Associated Protein) was identified as a 55 kDa polypeptide in
the medium and large HP1 complex from early Drosophila embryos. A) Coomassie-staining
of polypeptides eluted from a control IgG (lanes 1, 3, and 5) anti-HP1 immunoaffinity (lanes 2, 4,
and 6) column loaded with gel filtration fractions containing the small (lanes 1 and 2), medium
(lanes 3 and 4) and large (lanes 5 and 6) HP1 complexes, respectively (Huang et al., 1998;
Shareef et al., 2003). Positions of molecular weight markers shown on left and polypeptides with
molecular weights for HP1 (HP1), ORC subunits 2 and 6 (ORC2 and ORC6), and unknown
polypeptides (p55, p40, and p35) on the right. B) Molecular structure of HOAP showing Nterminal region of similarity to the HMG box DNA binding motif (slashed lines) and three novel
PETEMNE repeats responsible for HP1 binding in the C-terminus (horizontal lines) (Badugu et
al., 2003)
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A)

B

Figure 1.2. HOAP and HP1 have partially overlapping distributions on polytene
chromosomes from larval salivary glands. A) HOAP immunostaining shows prominent
association of it with telomeres (short arrows). Weaker immunostaining is also observed in
regions of pericentric heterochromatin (long arrows) and euchromatin (stars) (Badugu et al.,
2003). B) HP1 immunostaining shows pronounced enrichment throughout the chromocenter
(long arrows) and at telomeres (short arrows). Weaker signals were also observed at many
euchromatic sites (stars) (Shareef et al., 2003)
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Figure 1.3. HOAP/HP1 ChIP on chip analysis of region of 3L heterochromatin. The
log2Ratio (Y axis) for enrichment of a sequence in the HOAP- (red solid line) or HP- (green
dashed line) ChIP fraction relative to the input (normalized against a set of euchromatic gene
standards) is plotted along the X-axis showing the Drosophila genome assembly coordinates
(GBrowse) (Tweedie et al., 2009). Red stars indicate enrichment associated with flanking testisspecific genes. Blue stars indicate enrichment associated with flanking transposable elements.
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Table 1.1. Summary of the results of cav1 expression profiling study.

Testis &
Ovary Embryo

Ovary

Carcass
Midgut

Multiple

Multiple

Rare

Testis

Rare

Tissue

# Genes

Fraction

Tissue

# Genes

Fraction

Testis
Multiple
Rare
Testis & Ovary
Ovary
Embryo
Total

95
34
4
4
4
1
142

67.0%
23.9%
2.8%
2.8%
2.8%
0.7%
100%

Multiple
Rare
Midgut
Carcass

24
8
8
1

58.5%
19.5%
19.5%
2.5%

Total

41

100%

Genes with A) reduced or B) elevated transcript levels were characterized according to their
expression profiles in wild type animals using a combination of previously published cDNA
representation (Andrews et al., 2000; Stapleton et al., 2002) and microarray expression
profiling data (Arbeitman et al., 2002; Chintapalli et al., 2007; Parisi et al., 2004).
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Chapter Two
HOAP is required for Male Viability

RT-PCR assays of a select group of euchromatic genes from the cav expression profiling
study

Before beginning the experiments to determine the nature of the effect of the cav1 mutation on
testis-specific transcripts, I applied semi-quantitative RT-PCR assays to determine the validity of
the microarray findings. Genes with either testis-specific or testis-non-specific normal expression
patterns (Figure 2.1), five with decreased transcript levels (left) and three with increased
transcript levels (right), were selected for the analysis. The Drosophila RpA-70 gene, which was
unaffected in the expression profiling study, was used as the normalizing standard. Figure 2.1B
shows the results of these assays to be consistent with the results of the microarray study.
Because HOAP interacts with HP1 and RNAi knockdown of the gene for HP1 [Su(var)205] also
causes enhanced male lethality (Liu et al., 2005), I also examined the transcript levels for these
genes in Su(var)205 mutants. The results were similar to those of RNA from the cav1 mutant,
which may indicate a shared role for the two proteins in regulating this class of genes.
Alternatively, these genes may be similarly indirectly affected in both mutants, as a result of the
requirement for both for male viability.

Ratio of sex-non-specific to female-specific tra transcripts is altered in cav1 mutant
As discussed earlier, the reduced testis-specific transcript levels could reflect underrepresentation of males in the cav1 mutant larvae. To determine whether somatic sex-specific
transcripts are also reduced in the cav1 mutant, I used RT-PCR assays to measure the ratio of the
sex-non-specific- to female-spliced forms of the sex differentiation gene in the soma, transformer
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(tra), in RNA from the cav1 mutant. The tra gene is regulated by the SXL protein to undergo
alternative splicing to produce a female-specific transcript in females in addition to a non-sexspecific transcript in both sexes (Boggs et al., 1987). The non-sex-specific transcript is not
protein coding. In females only, tra pre-mRNA splicing is repressed by SXL protein to produce a
protein-coding mRNA. The results of semi-quantitative RT-PCR experiments showed that the
ratio of the non-sex-specific tra transcript to the female-specific one in the RNA sample from
cav1 mutant larvae is reduced by 6-8 folds relative to that in wild type animals (Figure 2.2).
Similar results were obtained for larvae that were mutant for HP1 (Su(var)2055/Su(var)20504).
The over-representation of the female-specific tra transcript in the Su(var)205 mutants is
consistent with the reduced male viability observed in animals with reduced HP1 levels through
RNAi knock-down (Liu et al., 2005). The similar reduction in the female-specific transcript in
mutants for HOAP may indicate that males are similarly under-represented in it.

Males are under-represented in cav1 mutant larvae
To more directly determine the ratio of males to females in the cav1 mutant at the larval stage,
larval gonad morphology was used to sex them. The larval gonads of both sexes appear as small
transparent circular regions, surrounded by fat tissues, but male gonads are considerably larger
and can be used as means to sex larvae. I found none of the cav1 mutant larvae to contain gonads
of the size expected for males. However, this result could also reflect a defect in male gonad
development in the cav1 mutant, or a mitotic defect in stem cells of the gonad. I, therefore, used
an X-linked genetic marker (y+) for larval mouth hook color as an alternative method to
determine the sex of larvae that does not depend on proper gonad development. To this end, cav1
fathers carrying the wild type y+ allele on their single X chromosome were crossed to cav1
mothers carrying a y- allele on both X chromosomes. All male progeny from this cross would
carry the y- allele and have brown mouth hooks, and thus, they could be differentiated from all
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female progeny carrying y+ and having black mouth hooks. The results indicated a 2.8-fold
under-representation of male larvae in the cav1 homozygous mutant (P < 0.01) (Table 2.1). A
smaller, but insignificant (P > 0.05), under-representation of males was observed in the cav1
heterozygous larvae. Interestingly, male gonad size seemed to be reduced in the surviving cav1
mutant male larvae. This reduced size could reflect a sex transformation of male gonad or a
mitotic defect in stem cells of the gonad, as well as a requirement for HOAP for survival of males
to the larval stage. No sex-specific viability defect was observed in cav1 heterozygous animals at
adult stage.

Ubiquitous reduction of cav transcripts through interference RNA expression reduces adult
male viability

Liu et al. (2005) (Liu et al., 2005) used the GAL4/UAS binary system to drive the ubiquitous
expression of a UAS- transgene for interference RNA against Su(var)205 and showed that male
viability is preferentially reduced when Su(var)205 transcript levels are reduced to between 6090% of wild type levels. The GAL4/UAS system (Duffy, 2002) consists of two parts: the Gal4
gene encoding a yeast transcription activator, placed under the control of a Drosophila tissue
specific promoter, is used to drive the expression of a target gene controlled by a UAS sequence
(Upstream Activation Sequence) to which GAL4 protein specifically binds to activate
transcription.

To determine if partial HOAP knockdown would similarly preferentially affect male viability, I
used the GAL4/UAS binary system to express a pUAST transgene for cav interference RNA (cav
RNAi), which had been made by a former member of the lab (Youngdong Yoo). I used the
Act5C-GAL4 driver which is expressed ubiquitously throughout the animal’s life span to drive
expression of cav interference RNA (UAS-cav-RNAi). Reciprocal crosses were used in the
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assays. Expression of cav RNAi from two transgenic lines, F8 and #543, through a maternallycontributed Act5C-GAL4 driver, resulted in a 2.5-fold and 1.5-fold reduction in the viability of
adult males relative to females, respectively (Table 2.2). A third cav RNAi transgenic line, #662,
showed a complete lethality of both males and females when driven by the same GAL4 driver
(Table 2.2). The reciprocal cross, in which the Act5C-GAL4 driver was paternally contributed,
was done in order to determine the requirement for early expression of GAL4 protein in reducing
male viability. The results showed that the male viability was reduced by 1.4 fold in this cross,
lower than 2.5-fold reduction observed when the Act5C-GAL4 driver was contributed by the
mother. While maternal expression of GAL4 protein was not sufficient to reduce viability of
male progeny lacking the GAL4 transgene, the stronger effect on male viability in this cross
suggests a requirement for early knockdown of cav in producing the maximum effect.

I used semi-quantitative RT-PCR assays of RNA extracted from larvae carrying both transgenes
(Act5C-GAL4/UAS-cav-RNAi), identified through their lack of the GFP marker on the
homologous balancer chromosome. The results (Figure 2.4) showed the severity of the effect on
male viability in different transgenic lines correlates with the degree to which endogenous cav
mRNA is reduced in each. The endogenous cav mRNA levels are decreased by at least 100 fold
in line #662, which resulted in a complete lethal phenotype for both sexes, in comparison to the
~5- fold reduction in line F8, which caused 2.5-fold reduction in male viability. The results are
consistent with partial knockdown of HOAP causing preferential male lethality and complete loss
of HOAP causing lethality of both sexes, similar to what was observed with RNAi knockdown of
HP1 (Liu et al., 2005).

I also crossed female and male adults carrying both the Act5C-GAL4 driver and UAS-cav-RNAi
transgene to wild type animals and examined the ratio of male to female in their progeny. The
results, as displayed in Table 2.3, showed that there is no significant sex-specific effect on
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viability of progeny in either cross. This result could indicate that HOAP is not required either
paternally or maternally for male viability. Alternatively, the heat shock promoter of the pUAST
vector used in these experiments is now known to express poorly in germline cells, and therefore,
may not have provided sufficient expression of cav RNAi to produce parental effects.

Male viability is reduced in heterozygotes for a newly recovered cav allele
Finally, a dominant reduced male viability phenotype was observed in a newly recovered cav
allele (cav2248) which contains a G>A transition at nucleotide 111 of the HOAP coding sequence
resulting in a nonsense codon at amino acid 37 of the 377 amino-acid HOAP-coding sequence.
This cav2248 allele apparently behaves as a dominant negative allele, as its effect on male viability
is comparable to that caused by a ~5-fold reduction of HOAP by cav RNAi knockdown but
stronger than a 2-fold reduction caused by a deletion that removes the chromosome interval
containing the cav gene [Df(3R)crb-F89-4] in heterozygous condition. Adult male viability is
reduced by 1.8-fold in animals carrying the cav2248 allele in heterozygous condition (Table 2.4).
The cav2248 allele also caused smaller, but significant, reduction in viability of male progeny that
was observed when heterozygous males for it were crossed to wild type mothers. Furthermore,
the paternal mutation also affected the viability of male progeny lacking the mutation and had an
effect that was almost as dramatic as that when the mutation was present in both parents (Table
2.4).

This cav2248 allele is associated with embryonic lethality in both heterozygotes and homozygotes
for it. No non-Tb larvae were observed from cav2248/TM6Tb crossed to itself or to cav1/TM6Tb.
Embryos that were heterozygous for the allele were identified through their moderate level of
GFP expression from the GFP-marked balancer chromosome (twi-GAL4, UAS-GFP marked
balancer) and were observed to arrest development late in embryogenesis at a time when denticle
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belts have become barely visible (arrows in Figure 2.4A). Homozygotes for cav2248 had an earlier
lethal phase before denticle belts were visible (Figure 2.4A) that was associated with a high
frequency of telomeric defects as observed through DAPI-staining (Figure 2.4B) . Telomeric
fusions were not observed at increased frequency in cav2248 heterozygous males.

Discussion
HOAP is a novel HP1-interacting protein which is associated with telomeres, pericentric
heterochromatin and many euchromatic sites. Consistent with its strong telomeric staining,
HOAP has been shown to protect telomeres from end-to-end fusions. In order to study its nontelomeric functions, a microarray experiment was applied and the results showed the majority of
genes with decreased transcript levels are testis-specific. This result could either indicate a role of
HOAP in regulating testis-specific gene expression or a requirement for it for male viability,
resulting in under-representation of males in cav1 mutant larvae.

I used genetic assays to show that HOAP is, indeed, required for male viability. Reduced male
viability was observed in cav2248 heterozygotes, cav1 homozygotes, and animals expressing cav
interference RNA. The viability of male progeny from the cross between males carrying Act5CGAL4 and females carrying UAS-cav-RNAiF8 was significantly reduced 1.4-fold (p < 0.05), but
the more pronounced reduction (2.5-fold, p < 0.01) in the reciprocal cross indicated a need for
early knockdown through pre-loading of the embryos with maternal GAL4 protein.

The requirement of HOAP for male viability does not appear to be strongly dependent upon its
telomeric function. Telomere fusions were not observed more frequently in males than females
of cav1 mutant larvae (Yikang Rong, personal communication), and they were not observed at
high frequency in cav2248 heterozygous males that die as late staged embryos. It should be noted
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that HOAP may also function directly or indirectly in male gonad development, as evidenced by
the reduced size of the larval gonad in cav1 mutant males.

To elucidate the cause and mechanism of this reduced male viability, which presumably reflects a
function for HOAP at non-telomeric sites, the following three hypotheses will be tested:

A) The heterochromatic Y chromosome in males exacerbates the lethality associated with
the telomeric defects in mutants for HOAP, by more rapidly depleting HOAP from
telomeres.
B) A defect in the sex determination pathway that prevents dosage compensation from
properly occurring in males. This defect could occur early in the decision of whether to
activate dosage compensation in males or in the process of dosage compensation itself.
C) A defect in gene expression required for male viability.

Copyright © Hui Li 2011
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A)
Genes with decreased expression in cav1
microarray
Gene
Log2R P
Expression
name
value
Pattern
CG2127
-4.72
0.005 testis
CG8701
-7.77
0.032 testis
CG4669
-5.29
0.006 testis
CG16741
-7.06
0.017 testis
CG8914
-9.27
0.002 testis

Genes with increased expression in cav1
microarray
Gene
Log2R P
Expression
name
value
Pattern
CG5778 19.63 0.037 Multiple
CG1304 4.08
0.036 Multiple
CG2071 6.44
0.016 Multiple

B)

>

>

Figure 2.1. Results of cav1 microarray study were corroborated by RT-PCR assays.
A) Genes selected for RT-PCR assays, include five with decreased transcript levels (left) and
three with increased transcript levels in cav1 mutant larvae (right). B) RT-PCR assays of genes
with decreased transcript levels (left) and increased transcript levels (right) in a ten-fold dilution
series of RNA from wt, Su(var)2055/Su(var)20504 and cav1 larvae are shown. RpA-70 was used
as the normalizing standard. The identity of PCR product of unexpected size for CG4669
transcript (indicated by >) is unknown.
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Figure 2.2. Female-specific tra transcript is increased 6 to 8-fold in cav1 and Su(var)205
mutant larvae relative to wild type. A) Primer pairs P1 and P2 used to detect sex nonspecific and female tra transcripts in B) RT-PCR assays of a ten-fold dilution series of RNA
extracted from wild type, Su(var)2055/Su(var)2054 and cav1 larvae are shown. The size of the
products expected from the sex non-specific and female-specific tra transcripts are indicated.
* indicates a product of unexpected size of unknown identity.
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Figure 2.3. Endogenous cav RNA level was reduced in transgenic animals expressing cav
interference RNA. RT-PCR assays using a ten-fold dilution series for RNA templates from wt
and UAS-cav-RNAi/Act5C-GAL4 larvae are shown. The cav mRNA level was reduced by 10fold in line F8 which results in reduced male viability and by 100-fold in line #662 which reduces
viability of both sexes (right) in comparison to RpA-70 normalizing standard (left).
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Figure 2.4. Homozygotes and male heterozygotes for the cav2248 allele arrest development
during embryogenesis . A) Cuticle preparations of cav2248 homozygous and heterozygous
embryos that fail to progress to the larval stage show that heterozygotes (the majority of which
are males) die late in embryogenesis when denticle belts are barely visible (short arrows),
whereas homozygotes die earlier in embryogenesis before denticle belt formation. B) DAPI
nuclear staining shows the early lethality for cav2248 homozygous embryos to be associated with
telomeric end-to-end fusions (short arrows), whereas few defects were observed in heterozygous
embryos arrested later in development.
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Table 2.1. Males were under-represented in cav1 homozygous larvae.
A)
Larvae Progeny
cav1/ cav1
cav1/TM6Tb

♀y-/ y-; cav1/TM6Tb X ♂y+/ Y; cav1/TM6Tb
Phenotype
Number
♀:♂
y+ ♀
119
2.83 : 1 ***
y ♂
42
y+ ♀
130
1.11 : 1
y ♂
117

B)
Adult Progeny
cav1/TM3Sb

♀ cav1/TM3Sb X ♂ cav1/TM3Sb
sex
Number
♀:♂
♀
186
1.08 : 1
♂
172

A) Using the dominant y+ genetic marker required for pigmentation of larval mouth hooks to sex
individual larvae and the dominant Tubby (Tb) marker on the TM6 balancer chromosome for
Chromosome 3 to identify homogyzous and heterozygous cav1 larvae, a significant reduction in
the number of male vs. female larvae, relative to their heterozygous siblings (n>161, Z=5.2, p <
0.01), was observed. B) No effect on male viability was observed in cav1 heterozygous adults.
TM3 is a balancer chromosome for Chromosome 3 that carries a dominant Stubble (Sb) marker,
which is visible in adults.
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Table 2.2. Enhanced male lethality was observed in animals expressing cav interference
RNA.
A)

Adult Progeny
UAS-cav-RNAi/
Act5C-GAL4
UAS-cav-RNAi/CyO
Act5C-GAL4/CyO

♀ Act5C-GAL4/CyO X ♂ UAS-cav-RNAi/CyO
#543
F8
Total ♀ : ♂
Total ♀ : ♂
♀ 179
1.54:1***1 608
2.49: 1***2
♂
♀
♂
♀
♂

116
112
131
108
121

0.85 : 1
0.89 : 1

244
622
606
579
564

1.03 : 1
1.03 : 1

#662
Total
0
0
134
143
121
101

♀:♂
0:0

0.94 : 1
1.20 : 1

B)

♀ UAS-cav-RNAiF8/CyO X ♂ Act5C-GAL4/CyO
Adult Progeny
Total
♀:♂
UAS-cav-RNAi/Act5C-GAL4
♀
516
1.41 : 1**
♂
366
UAS-cav-RNAi/CyO
♀
528
0.99 : 1
♂
531
Act5C-GAL4/CyO
♀
518
1.22 : 1
♂
423

A) Significant reduction in male viability was observed in multiple UAS-cav-RNAi transgenic
lines driven by the ubiquitous Act5C-GAL4 driver in mothers, in comparison to their siblings
carrying either transgene alone (***1: n>852, Z = 7.8, p < 0.01; ***2: n>295, Z = 3.7, p < 0.01).
B) Male viability was reduced less, but also significantly, in the reciprocal cross in which the
Act5C-GAL4 driver was contributed by their fathers (**: n>882, Z = 3.0, p < 0.05).
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Table 2.3. Sex-specific viability was not affected in progeny from crosses between animals
carrying both the Act5C-GAL4 and UAS-cav-RNAiF8 in either parent crossed to wild type.
A)
Adult Progeny
UAS-cav-RNAiF8/+
Act5C-GAL4/+

B)
Adult Progeny
UAS-cav-RNAiF8/+
Act5C-GAL4/+

♀ Act5C-GAL4/ UAS-cav-RNAiF8 X ♂ wt
Sex
Total
♀
223
♂
209
♀
225
♂
222
♀ wt X ♂ Act5C-GAL4/ UAS-cav-RNAi F8
Sex
Total
♀
260
♂
298
♀
256
♂
291

♀:♂
1.07 : 1
1.01 : 1

♀:♂
0.87 : 1
0.88 : 1

A) No sex-specific lethality was observed in progeny from the cross between Act5C-GAL4/
UAS-cav-RNAiF8 mothers and wt fathers. B) Male viability was insignificantly reduced in
progeny from the cross between Act5C-GAL4/ UAS-cav-RNAiF8 fathers and wt mothers against
hypothetical 1:1 (*: n>558, Z = 1.2, p > 0.10).
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Table 2.4. Dominant reduced male viability was observed in progeny from animals that
were heterozygous for the cav2248 allele.
A)
Adult Progeny
cav2248/ TM3Sb

B)
Adult Progeny
cav2248/ +
TM3/+

C)
Adult Progeny
cav2248/ +
TM3/+

♀ cav2248/TM3Sb X ♂ cav2248/TM3Sb
Sex
Number
♀:♂
♀
202
1.84 : 1 **
♂
110
♀ cav2248/TM3Sb X ♂ +/+
Sex
Number
♀
161
♂
124
♀
107
♂
109
♀ +/+ X ♂ cav2248/TM3Sb
Sex
Number
♀
195
♂
115
♀
170
♂
104

♀:♂
1.30 : 1
0.98 : 1

♀:♂
1.70 : 1**
1.63 : 1

A) A strong and significant reduction in male viability was observed in progeny from parents that
both had a cav2248/TM3Sb genotype against hypothetical 1:1 (n>274, Z=2.9, p < 0.05). B) A
smaller but statistically insignificant reduction in male viability was observed in progeny from
cav2248 heterozygous mothers crossed to wild type (n>285, Z=1.5, p > 0.05). B) A significant
reduction in male viability was observed when both classes of progeny from fathers carrying
cav2248 allele in heterozygous condition, against hypothetical 1:1 (n>274, Z=2.9, p > 0.05).
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Chapter Three
The Role of the Y Chromosome in Male Lethality

Introduction
In order to test the hypothesis that the heterochromatic Y chromosome in males exacerbates the
effect of reducing HOAP by titrating away heterochromatin proteins and more rapidly depleting
it, I introduced a Y chromosome into females and an extra Y chromosome into males expressing
cav interference RNA. The Y chromosome is not required for Drosophila male viability or
sexual differentiation. However, because it is almost entirely composed of heterochromatin and
has numerous binding sites for heterochromatin proteins, it can suppress positive effect
variegation (Spofford, 1976). It is, therefore, possible that it could titrate out heterochromatin
proteins to make males more vulnerable to reduced levels of HOAP and, therefore, more
susceptible to telomeric fusions. In fact, the male-specific lethality of mutants for bonus, the
TIF1β HP1-interacting protein, which acts as a suppressor of variegation, was shown to require
the presence of a Y chromosome (Beckstead et al., 2005). Beckstead et al. (2005) showed that a
loss-of-function allele of bonus (bon434) caused an almost complete male lethality under
homozygous condition. This male lethality was rescued when C(1:Y); bon43/TM6 males were
crossed to bon43/TM6 females to generate male bon434/ bon434 lacking a Y chromosome (XO).
Interestingly, the bon434/ bon434 females, also generated from this cross, which carry a Y
chromosome (XXY), exhibited 100% lethality. Similar effects on sex-specific viability were also
observed with introduction of extra heterochromatin derived from the X chromosome. I,
therefore, used a similar approach to test the role of the Y chromosome in the HOAP-dependent
male viability phenotype.
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Results
To test whether the reduced male viability in animals containing reduced HOAP is similarly due
to the titrating effect of the Y chromosome, the C(1;Y) chromosome, formed by a rearrangement
that fuses an X and Y chromosome, was introduced into both males and females expressing cav
interference RNA (Table 3.1). If the reduced male viability is due to the titrating effect of the Y
chromosome, we would expect that introduction of this compound chromosome into either
females or males expressing cav interference RNA would reduce viability of animals of either sex
in comparison to those lacking it. The results in Table 3.1 showed the C(1;Y) chromosome to
reduce viability of both males and females by 30% relative to their siblings of the same genotype
lacking C(1;Y). But the magnitude of this effect (30%) was not measured as significant (p = 0.09
> 0.05). By contrast, the sex of the animals expressing cav RNAi had a significant effect (p <
0.01) in both classes of progeny, those both with and without C(1;Y). Male viability was reduced
2.3-fold in animals expressing cav interference RNA in both classes.

Discussion
The Y-dependent lethality for both male and female bon434/ bon434 mutants indicated that the
presence of the Y chromosome as a sink for heterochromain proteins, rather than animal’s sex, is
primarily responsible for the reduced male viability of these mutants. Beckstead et al. (2005)
(Beckstead et al., 2005) also observed bon434/ bon434 female flies carrying additional X-linked
heterochromatin had reduced viability, and, therefore viability was reduced by introducing any
additional heterochromatin. Mutants for HOAP differ from bonus in this regard. Introduction of a
Y chromosome had a small effect on the viability of both male and female progeny, whether or
not they expressed cav RNAi. This effect was significantly smaller than 2.5-fold reduction in
male viability observed in both C(1;Y)-bearing and C(1;Y)-lacking animals expressing cav
interference RNA. When cav interference RNA is expressed, the ratio of female to male progeny
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in the presence of C(1;Y) (2.31:1), is very close to that in the absence of it (2.30 :1). Taken
together, these results indicate that an interaction between reduced HOAP levels and the Y
chromosome is not the primary cause for the reduced viability of males expressing cav
interference RNA. This led me to next test my second hypothesis that dosage compensation and
sex determination are affected in cav mutants and a defect in those processes are responsible for
the male lethality.

Copyright © Hui Li 2011
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Table 3.1. Titrating effect of a heterochromatic Y chromosome does not account for the
reduced viability of males with reduced HOAP.
A)

♀ C(1;Y)/X; Act5C-GAL4/CyO X ♂ X/Y; UAS-cav-RNAiF8/CyO
Adult Progeny
Number X : (1;Y) ♀ : ♂
♀ X/X; UAS-cav-RNAiF8 /Act5C-GAL4
326
1.31 : 1* 2.35 : 1***
♀ C(1;Y)/X; UAS-cav-RNAiF8 /Act5C-GAL4
248
2.32 : 1
♂ X/Y; UAS-cav-RNAiF8 /Act5C-GAL4
139
1.30 : 1
♂ C(1;Y)/Y; UAS-cav-RNAiF8 /Act5C-GAL4
107
♀ X/X; UAS-cav-RNAiF8 /CyO
♀ X/X; Act5C-GAL4/CyO
♀ C(1;Y)/X; UAS-cav-RNAiF8 /CyO
♀ C(1;Y)/X ; Act5C-GAL4/CyO
♂ X/Y; UAS-cav-RNAiF8 /CyO
♂ X/Y; Act5C-GAL4/CyO
♂ C(1:Y)/Y; UAS-cav-RNAiF8 /CyO
♂ C(1;Y)/Y; Act5C-GAL4/CyO

686

1.10 : 1

623
600

1.14 : 1
1.50 : 1

1.44 : 1

416

B)

♀ C(1;Y)/X; UAS-cav-RNAiF8 /CyO X ♂ X/Y; Act5C-GAL4 /CyO
Adult Progeny
Number X : (1;Y) ♀ : ♂
♀ X/X; UAS-cav-RNAiF8 /Act5C-GAL4
600
0.97 : 1
1.28 : 1
♀ C(1;Y)/X; UAS-cav-RNAiF8 /Act5C-GAL4
618
1.15 : 1
♂ X/Y; UAS-cav-RNAiF8 /Act5C-GAL4
467
0.87 : 1
♂ C(1;Y)/Y; UAS-cav-RNAiF8 /Act5C-GAL4
539
♀ X/X; UAS-cav-RNAiF8 /CyO
♀ X/X; Act5C-GAL4/CyO
♀ C(1;Y)/X; UAS-cav-RNAiF8 /CyO
♀ C(1;Y)/X ; Act5C-GAL4/CyO
♂ X/Y; UAS-cav-RNAiF8 /CyO
♂ X/Y; Act5C-GAL4/CyO
♂ C(1:Y)/Y; UAS-cav-RNAiF8 /CyO
♂ C(1;Y)/Y; Act5C-GAL4/CyO

1146

0.96 : 1

1193
1140

1.01 : 1
1.02 : 1

0.97 : 1

1172

Introduction of an extra Y chromosome as C(1;Y) to males and a Y chromosome to females
expressing cav RNAi did not significantly reduce the animal viability in cross A) in which
Act5C-GAL4 is contributed by the mothers or B) the cross which Act5C-GAL4 is contributed by
the fathers. The numbers for UAS-cav-RNAiF8/CyO and Act5C-GAL4/CyO sibling animals
were grouped together because they were not phenotypically distinguishable. (*: n>574, Z=1.7,
0.1> p > 0.05) (***: n>465, Z=6.6, p < 0.01)
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Chapter Four
Role of Defects in the Sex Determination Pathway in Male Lethality

Introduction
Genetic sex determining systems result in one sex carrying two copies of a sex chromosome
while the opposite sex carries only a single copy. Dosage compensation processes allow
equivalent expression of genes on the sex chromosome in both sexes. In the X-Y sex determining
system of Drosophila, transcription from the single X in males is hyperactivated, and defects in
this process result in male lethality (Lucchesi et al., 2005). A defect in male dosage
compensation could occur early in the sex determination pathway in the decision to undertake a
male vs. female path or late in the mechanics of the dosage compensation process.

The sex lethal (Sxl) gene is the master regulator gene of the sex determination pathway in
Drosophila and controls genes for both male-specific dosage compensation and sexual
differentiation. Sex Lethal (SXL) protein is only active in females, with an X chromosome to
autosome ratio (X:A) of 1.0 and inactive in males with an X:A ratio of 0.5 (Cline, 1984). SXL is
an RNA-binding protein that functions as a splicing regulator of downstream genes in both
dosage compensation and sexual differentiation, as well as its own transcripts. In the sexual
differentiation pathway, it controls the female-specific splicing of pre-mRNA from the
transformer (tra) and transformer 2 (tra-2) genes, which direct female somatic development
(Burtis et al., 1991; Erdman and Burtis, 1993). In the dosage compensation pathway, the absence
of SXL protein in males allows transcripts encoding protein Male Specific Lethal-2 (MSL-2), one
component of the Dosage Compensation Complex (DCC), to undergo proper splicing and
translation to form functional protein required to target other non-sex-specific components of the
DCC to the male X chromosome (Bashaw and Baker, 1995). The critical decision in this
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pathway is made during early embryogenesis with the activation of the Sxl establishment
promoter (SxlPe) in females only, generating a transcript that is constitutively spliced into a
mature mRNA encoding functional SXL protein (Keyes et al., 1992). This SXL protein is
required for proper female-specific splicing of transcripts produced from the Sxl maintenance
promoter (SxlPm) later in development in both sexes. The end result is the production of
functional SXL protein needed for repression of male-specific splicing and translation of msl-2
transcripts in females. Inappropriate expression of SXL in males prevents expression of MSL-2
needed for male dosage compensation, resulting in male-specific lethality (Lucchesi et al., 2005).
Loss of SXL expression in females causes inappropriate X chromosome dosage compensation in
females and female-specific lethality (Lucchesi et al., 2005).

Sxl transcripts are inappropriately spliced in mutants for HOAP or HP1
In order to test the hypothesis that an early defect in male-specific dosage compensation is
responsible for the reduced viability of males containing reduced levels of HOAP, I first applied
RT-PCR assays to examine sex-specific splicing of Sxl transcripts in RNA extracted from
individually sexed cav2248/+ and cav1 embryos that failed to progress to the larval stage (Figure
4.2). A GFP reporter expressed from the embryonic twi promoter on the homologous balancer
chromosome (twi-GFP) was used to identify embryos of the appropriate genotype. Nucleic acids
were extracted from individual embryos of the appropriate genotype and used in PCR assays with
primers for the Y-linked kl-2 gene to determine their sex. Nucleic acid preparations that
generated a Y-specific PCR product were identified as male-derived and pooled for purification
of cav mutant male RNA. Those that did not give rise to Y-specific PCR products but did
produce a product for the RpA-70 positive control gene were assumed to be derived from females
and were pooled for purification of cav mutant female RNA. RT-PCR assays of each sample
were then used to monitor the mode of SXL-regulated splicing of SxlPm-derived transcripts. RpA-
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70 primers were used in similar assays to assure the quality of each RNA template. Two primer
pairs (P1/P3 and P2/P3 in Figure 4.2A) were used to detect Sxl transcripts that had undergone
either the male- or female-specific mode of splicing. RNA from similarly staged yw embryos was
used as the control for this experiment. The results in Figure 4.2B showed that the P1/P3 primer
pair amplified the expected 269 bp product from the female-specific transcript and 378 bp
product from the male-specific transcript in RNA from wild type embryos. The P2/P3 pair
amplified the expected 215 bp product from the male-specific transcript from wild type male
embryos only. By contrast, we were able to detect a minor fraction of the 269 bp P1/P3-primed
PCR product from the female-specific transcript in the RNA sample from heterozygous cav2248
males. We did not, however, amplify the 215 bp product from the male-specific Sxl transcript in
RNA from female cav mutant embryos.

Because HP1 interacts with HOAP, and HP1 knock-down also preferentially reduces male
viability, I applied similar RT-PCR assays of Sxl transcripts in RNA isolated from male and
female larvae that were mutant for the HP1-coding gene [Su(var)205]. Trans-heterozygous
Su(var)2055/Su(var)20504 larvae were collected from a cross of female Su(var)2055/Act5C-GFPCyO to male Su(var)20504/ Act5C-GFP-CyO. Larval gonad morpoholgy and PCR assays with Ylinked primers were used to sex individual larvae before RNA was then purified from the
extracted nucleic acids. The same primer pairs (P1/P3 and P2/P3 in Figure 4.2A) were used to
monitor splicing of Sxl transcripts in male and female Su(var)205 mutant larvae. In contrast to
what was observed in cav mutants, the assay with the P1/P3 primer pair detected a minor fraction
of the female-specific transcript in RNA from Su(var)205 mutant male larvae and the P2/P3
primer pair detected the presence of male-specific Sxl transcripts in RNA from Su(var)205 mutant
female larvae.
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Mutations in the HOAP- and HP1-encoding genes genetically interact with Sxl mutations
The presence of aberrant Sxl splice forms in mutants for HOAP and HP1 supports a defect in the
sex determination pathway in both mutants and also suggests a defect in the critical early decision
as to whether to express SxlPe. I, therefore, applied genetic assays to further explore the
relationship between these heterochromatin proteins and the sex determination pathway. First,
the effect of introducing a Sxl loss of function allele (Sxl7B0) into cav2248 heterozygous males was
examined. I reasoned that if the male lethality of the cav2248 mutant is due to inappropriate
expression of Sxl, it should be at least partially rescued by a reduced dose of Sxl. Although I was
unable to use genetic markers to identify progeny carrying the Sxl mutation and compare their
viability to those lacking it, the total male viability of the cav2248 mutant was rescued by either
paternal or maternal introduction of Sxl7B0 (Table 4.1).

Second, the effect of a maternal mutation in either cav or Su(var)205 on sex-specific viability of
progeny bearing a loss of function Sxl allele (Sxl7B0 or Sxlnull point null allele) was examined
(Table 4.2). Neither Sxl deficiency allele affected the sex-specific viability of progeny from wild
type mothers. The results of a cross between cav1 or cav2248 heterozygous females and Sxl/Y were
similar to those of crosses of either to wild type males. The cav1 mutation did not cause either
male or female lethality; the cav2248 mutation reduced the viability of male progeny by 30%,
similar to its effect when crossed to wt males. In contrast, the viability of female progeny from
the cross between Su(var)205 heterozygous females and Sxl/Y males was almost completely
abolished, regardless of whether the progeny carried the Su(var)205 allele (Table 4.3A). This
effect was strictly maternal, as it was not observed in the reciprocal cross (Table 4.3B). Out of
three Su(var)205 alleles used in these crosses, only two of them, the null Su(var)2055 containing a
frameshift mutation after ten amino acids and the C-terminally truncated Su(var)2054 allele,
exhibited this effect. The Su(var)2052 allele, which has a point mutation in the conserved
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chromo-domain responsible for binding di- and tri- MeK9 histone H3, did not reduce female
viability (Nielsen et al., 2001).

Although maternal mutations in cav did not affect female viability, the maternal effect of
Su(var)205 mutations on female viability was rescued by simultaneous introduction of a mutation
in cav and Su(var)205 into the mothers (Table 4.4A & B). The cav2248 completely rescued the
female lethality. The C-terminally truncated cav1 allele, which produces a protein with
compromised HP1-binding (Badugu et al., 2003; Cenci et al., 2003), was also able to partially
rescue the female lethality (Table 4.4C & D). The rescue activity of both alleles was also strictly
maternal; no effect on female viability was observed when the cav mutation was instead
introduced through the Sxl mutant fathers. Interestingly, introduction of the Su(var)2055 mutation
also rescued the male lethality associated with the cav2248 allele (Table 4.6).

Phosphorylation of HP1 on its hinge domain is required for its heterochromatin association (Zhao
and Eissenberg, 1999). To determine whether HP1 phosphorylation plays a role in the sexspecific viability effects of HP1, I examined the rescuing activity of UAS-driven HP1 transgenes
that mimic either hyper-phosphorylated (HP1E) or hypo-phosphorylated (HP1G) HP1, in
comparison to wild type HP1 (HP1wt) (Badugu et al., 2005). The HP1transgenes used in these
experiment express proteins contain a FLAG tag at the N-terminus from a heat shock 70 gene
promoter and UAS-binding site for GAL4 protein (Rorth, 1998). The HP1E transgene has been
mutated to change serine and threonine residue in a set of consensus PK-A sites in the hinge
domain to glutamic acid. In the HP1G transgene, the same residues have been mutated to glycine
to mimic hypo-phosphorylation. The results showed that all three forms were able to partially
rescue the female viability phenotype of Su(var)205 mothers when a nanos-GAL4 driver was
used to drive the expression in the maternal germline (Table 4.5).
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Mutants for HOAP and HP1 inappropriately express SxlPe-derived transcripts
The presence of inappropriately spliced Sxl transcripts in cav and Su(var)205 mutants in the RTPCR assays, combined with the genetic interactions between mutations in Sxl, cav, and
Su(var)205 suggested a role for HOAP and HP1 in sex determination. The presence of
inappropriate sex-specific Sxl transcripts in cav and Su(var)205 mutants could either reflect a
defect in the early decision of whether or not to fire SxlPe or a defect in the process of splicing Sxl
transcripts in these mutants. To elucidate the role of HOAP and HP1 at SxlPe, our collaborators in
Dr. Jamila Horabin’s lab at Florida State University performed in situ hybridization on embryos
from cav2248 and Su(var)2055 heterozygous parents with probes designed to specifically detect
transcripts from the two Sxl promoters (SxlPe and SxlPm). SxlPe-derived transcripts are produced
only in female wt embryos between cycle 12 -14 (those displaying two in situ hybridization dots
on the two X chromosomes of females) (Keyes et al., 1992). This is what observed in wt
embryos (Figure 5.1). Embryos from cav2248 parents, however, showed expression of SxlPederived transcripts two cycles earlier in 100% of females and inappropriate expression during
cycle 13 in at least some nuclei of 95% of male embryos (those displaying one in situ
hybridization dot per nucleus). In embryos from Su(var)2055 heterozygous parents, the SxlPe
expression in ~85% of female embryos was significantly weaker than in wt embryos. The timing
of this expression was the same as in wt embryos, and no SxlPe expression was observed in males.
No effect on SxlPm expression was observed in either mutant; this promoter remained silent at
these early stages of development.

Discussion
The aberrant presence of the female-form of SxlPm transcripts in male cav mutants could either
reflect a defect in the early decision not to fire SxlPe in males or a defect in the process of splicing
the SxlPm transcript. The first possibility is supported by the in situ hybridization data from our
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collaborators, Janel Rodriguez and Jamila Horabin at Florida State University. These
experiments showed that the SxlPe-derived transcript was inappropriately expressed in male
embryos and at earlier stages in female embryos from cav2248 parents, supporting a repressing
activity of HOAP at SxlPe in both sexes. Consistent with this, an introduction of Sxl7BO mutation
either paternally or maternally rescued male viability of cav2248 mutant. The Sxl7B0 mutation is
not inherited by male progeny when introduced paternally. Therefore, the increased ratio of male
progeny may result from rescue of the cav2248 paternal effect on male viability described earlier or
an effect on female viability that matches the effect on male viability.

Our data suggest a more complicated role for HP1 in regulating Sxl. Sex-specific Sxl transcripts
were inappropriately expressed in both sexes of embryos from Su(var)205 mutants. Again, this
could either suggest a defect in the early decision to fire SxlPe or a defect in the process of splicing
Sxl transcripts. The genetic assays showing the strict maternal effect of the Su(var)205 mutation
on female viability support an early requirement for HP1 in regulating Sxl. Moreover, in situ
hybridization data showing reduced expression of the SxlPe-derived transcript in Su(var)205
mutant females indicate an activating role for HP1 in regulating SxlPe. The complete rescue of the
maternal effect of Su(var)2055 mutant on female viability by the introduction of the cav2248 allele
into these mothers indicates an antagonistic role for HOAP and HP1 in regulating SxlPe. A
maternal Su(var)2055 mutation also rescues the male viability defect of the cav2248 mutant, further
illustrating the antagonistic relationship between the two proteins in regulating SxlPe. Moreover,
the partial rescue of the Su(var)205 maternal effect on female viability by the cav1 allele indicates
cooperative roles for the two proteins in regulating SxlPe, because the protein encoded by the cav1
allele is compromised for HP1-binding (Badugu et al., 2005; Cenci et al., 2003). This suggests
that HP1 plays a role in HOAP-repression of SxlPe. A repressing activity for HP1 at SxlPe is also
supported by the RT-PCR assays showing the aberrant expression of the female-form of the SxlPm
transcript in male Su(var)205 mutant larvae. The effects of HOAP and HP1 on SxlPe led us to
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apply Chromatin Immunoprecipitation (ChIP) assays to determine if these heterochromatin
proteins directly affect SxlPe expression through physical association with it.

Interestingly, the maternal effect for Su(var)205 on female viability is allele specific; it was not
observed for the Su(var)2052 allele carrying a point mutation in the MeK9-H3-binding
chromodomain (Nielsen et al., 2001). This indicates that the MeK9-H3-binding activity of HP1 is
not required for activation of Sxl. This does not exclude the possibility that this domain functions
in HP1 repression at SxlPe.

The partial rescue of lethality for female progeny from Su(var)205 mothers, by UAS-driven HP1
transgene (HP1wt, HP1E and HP1G) when maternally expressed through the germline-specific
nanos-GAL4 driver, may indicate that HP1 phosphorylation at these PKA consensus sites does
not play a role in regulating SxlPe or result from inadequate promoter activity in the germline from
the pUAST transgenes used in these experiments. These data also do not rule out the possibility
that phosphorylation at other HP1 residues is involved.

Copyright © Hui Li 2011
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Figure 4.1. Individual heterozygous cav2248 and homozygous cav1 embryos were sexed by
PCR using primers for the Y-linked kl-2 gene. Non-quantitative screens of individual cav2248/+
heterozygous embryos (top panels) and for cav1 homozygous embryos (bottom panels) to
determine their sex through PCR assays with primers for RpA-70 as positive control and the Ylinked kl-2 gene to sex them. The amount of template used in the RpA70 and kl-2 assays may not
be identical. Nucleic acids from a given sex and genotype were then pooled for RNA extraction.
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Figure 4.2. SxlPm transcripts are inappropriately spliced in sexed cav and Su(var)205
mutants. A) Primer pairs P1/P3 and P2/P3 were designed to amplify sex-specific Sxl transcripts.
Primers P1 and P3 are anchored in exons found in transcripts of both sexes. Primer P2 is
anchored in the male-specific exon of the male SxlPm-derived transcript. B) RT-PCR assays using
primer pair P1/P3 (top panel) and P2/P3 (bottom panel) and RNA from (left to right) female and
male wt and cav1 embryos; female and male wt and cav2248/+ embryos; and female wt and female
Su(var)2055/ Su(var)20504 larvae; male wt and male Su(var)2055/ Su(var)20504 larvae.
Arrowheads denote products from inappropriate sex-specific transcripts.
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Figure 4.3. SxlPe-derived transcripts are inappropriately expressed in embryos from cav or
Su(var)205 mutant parents. A) The SxlPe-derived transcript was expressed only between cycles
12-14 in wild type (Ore R) female embryos but was inappropriately expressed in 95% of male
embryos and two cycles earlier in 100% of female embryos from cav2248 heterozygous parents in
parallel in situ hybridization assays. B) in situ hybridization assays showed that expression of
SxlPe-derived transcript was significantly decreased in ~85% of female embryos from Su(var)2055
heterozygous parents in comparison to wt (Ore R) embryos in parallel in situ hybridization
assays.
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Table 4.1. The male lethality of the cav2248 mutant was rescued by introducing a Sxl loss of
function mutation either paternally or maternally.
A)
♀ cav2248/TM3
♂ cav2248/TM3

♀ cav2248/TM3 X ♂ cav2248/TM3
Adult Progeny
♀:♂
202
1.84 : 1
110

B)

♀ cav2248/TM3 X ♂ Sxl7BO/Y; cav2248/TM3
Adult Progeny
♀:♂
♀ Sxl7BO/+; cav2248/TM3
138
0.95 : 1***
2248
♂ cav /TM3
145
C)
♀ Total
♂ Total

♀ Sxl7BO/+; cav2248/TM3 X ♂ cav2248/TM3
Adult Progeny
♀:♂
205
1.04 : 1***
197

A) The cav2248 allele caused male lethality in heterozygous condition. B) Introduction of a loss of
function allele Sxl7BO paternally rescued male viability (n >283, Z=3.851, p < 0.01). C)
Introduction of Sxl7BO to the cav2248 mothers rescued male viability (n >402, Z=3.602, p < 0.01).
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Table 4.2. A maternal cav mutation did not reduce viability of female progeny lacking one
functional copy of Sxl.

cav1

♀ Sxl
cav/+
199

cav2248 (null)

217

Adult Progeny

7B0

♀ cav/TM3 x ♂ Sxl7B0 /Y
/+;
♂ +/Y;
TM3/+
cav/+
TM3/+
192
211
205
196

161

171

♀:♂
cav/+
0.94 : 1

TM3/+
0.94 : 1

1.35 : 1

1.15 : 1

A cross between cav1 heterozygous mothers and Sxl7BO/Y fathers did not cause sex-specific
lethality; a cross between cav2248 heterozygous females and Sxl7BO/Y males resulted in a slight,
but insignificant (*: n >367, Z=1.0, p = 0.31), male lethality that resembles that observed when
cav2248/+ mothers are crossed to wt fathers (Table 2.4 B).
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Table 4.3. Su(var)205 mutations have a strictly maternal effect on female viability.
A)

Su(var)205
Su(var)2054
Su(var)2052

♀ Su(var)205/CyO x ♂ Sxlnull /Y
♀ Sxl7B0/+;
♂ +/Y;
Su(var)205/+
CyO/+
Su(var)205/+ CyO/+
14
31
231
230
82
88
325
281
154
152
224
192

♀:♂
1 : 16.5***1
1 : 4.0***2
1 : 1.5

Su(var)2055
Su(var)2054

♀ Sxlf1/+;
Su(var)205/+
CyO/+
2
9
143
141

♀:♂
1 : 22***3
1 : 1.6

Adult Progeny
5

B)
Adult Progeny

♂ +/Y;
Su(var)205/+ CyO/+
122
120
233
210

♀ Sxl7B0 /FM7 x ♂ Su(var)2055/CyO
♀ Sxl7B0 /+
FM7/+
♀ Sxl7B0 /+
FM7/+
Suv
CyO
Suv
CyO Suv
CyO Suv
CyO
93
85
111
134
120
105 97
57

♀:♂
1 : 1.3

A) Viability of female progeny, was significantly reduced in the crosses between Su(var)205
mothers and Sxl7BO or Sxlf1 fathers. (***1: n >506, Z=14.3, p < 0.01) (***2: n >776, Z=11.5, p <
0.01) (***3: n >253, Z=11.4, p < 0.01). This effect was allele-specific; the Su(var)2052 allele,
which is defective for MeK9H3-binding, does not have this effect. B) Female viability was not
affected in the reciprocal cross showing the effect to be strictly maternal. In addition, effects on
Su(var)205-lacking as well as Su(var)205-bearing progeny, demonstrate a maternal effect.
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Table 4.4. HOAP and HP1 have antagonistic and cooperative effects on Sxl activity.
A)
Progeny
♀
♂
B)
Progeny
♀
♂
C)
Progeny
♀
♂
D)
Progeny
♀
♂

♀ Su(var)2055/CyO; cav2248/+ x ♂ Sxl7B0/Y
Number
231
1 : 0.87***
200
♀ Su(var)2055/CyO x ♂ Sxl7B0/Y; cav2248/+
Number
♀:♂
8
1 : 23
187
♀ Su(var)2055/CyO; cav1/+ x ♂ Sxl7B0/Y
Number
♀:♂
42
1 : 4.1***
172
♀ Su(var)2055/CyO x ♂ Sxl7B0/Y; cav1/+
Number
♀:♂
6
1 : 34
202

A) Simultaneous introduction of the cav2248 mutation and Su(var)205 mutation into mothers
completely rescued the lethality of female progeny from Su(var)205 mutant mothers and Sxl7BO
fathers (n >461, Z=14.9, p < 0.01). B) Introduction of the cav2248 mutation through the fathers did
not rescue the lethality of the female progeny from the Su(var)2055/+ mothers (n >195, Z=2.0, p
> 0.10). C) Simultaneous introduction of the cav1 mutation and Su(var)205 mutation into
mothers partially rescued the lethality of female progeny from Su(var)205 mutant mothers (n
>214, Z=3.9, p < 0.01). D) Introduction of cav1 mutation through the fathers failed to rescue the
lethality of the female progeny from Su(var)2055/+ mothers (n >208, Z=2.7, p > 0.10).
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Table 4.5. Maternal expression of HP1 transgenes partially rescued the female-specific
lethality of progeny from Su(var)205 mothers and Sxl/Y fathers.
A)
♀ nanos-GAL4/UAS-HP1wt#F3; Su(var)2055/+ X ♂ Sxl7BO/Y
Sexed Progeny
Total
♀:♂
♀
59
1 : 2.64***1
♂

156

♀ nanos-GAL4/+; Su(var)2055/+; UAS-HP1wt#F14/+ X ♂ Sxl7BO/Y
Sexed Progeny
Total
♀:♂
♀
37
1 : 4.24***2
♂

157

B)
♀ nanos-GAL4/+; UAS-HP1E#32/Su(var)2055 X ♂ Sxl7BO/Y
Sexed Progeny
Total
♀:♂
♀
48
1 : 3.71***
♂

178

C)
♀ nanos-GAL4/+; UAS-HP1G#M2/Su(var)2055 X ♂ Sxl7BO/Y
Sexed Progeny
Total
♀:♂
♀
45
1 : 2.82 ***
♂

127

Rescue relative to control female lethal phenotype in Table 4.3A was observed with nanosGAL4-directed female germline expression of either A) wild type HP1 (***1: n >215, Z=6.4, p <
0.01; ***2: n >194, Z=3.6, p < 0.01) , B) mutant HP1E mimicking hyper-phosphorylated HP1 (n
>226, Z=4.6, p < 0.01) or C) mutated HP1G mimicking hypo-phosphorylated HP1(n >172,
Z=5.6, p < 0.01).
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Table 4.6. Introduction of the Su(var)2055 mutation to zygotes rescued the reduced male
viability phenotype of cav2248 heterozygotes.
♀ Su(var)2055/CyO
Adult Progeny
Sex
Su(var)2055/+; cav2248 /+
♀
♂
CyO/+; cav2248 /+
♀
♂
5
Su(var)205 /+; TM3Sb /+
♀
♂
CyO/+; TM3Sb /+
♀
♂

x ♂ cav2248 /TM3Sb
Number
117
110
133
65
105
96
59
56

♀:♂
1.06 : 1
2.05 : 1**
1.09 : 1
1.05 : 1

The Su(var)205 mutation maternally rescues cav2248 paternal effect, but zygotic mutation is
needed to rescue the zygotic effect (n >198, Z=3.2, p < 0.05).
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Chapter Five
HOAP and HP1 are Physically Associated with SxlPe

Introduction
The genetic assays and in situ hybridization assays described in Chapter 4 prompted us to apply
chromatin immunoprecipitation (ChIP) assays to determine whether HOAP or HP1 directly affect
SxlPe activity by physically associating with SxlPe or other Sxl gene sequence.

I prepared cross-linked chromatin from staged collections of wild type embryos and performed
immunoprecipitations with antibodies directed against HP1 or HOAP, as well as a non-specific
IgG control. The ChIP experiments were applied to three different stages of embryos in order to
monitor both Sxl promoters before and during the time of SxlPe activity (1-3hr) and during SxlPm
activity (4-18hr). Chromatin from embryos at a stage that more precisely coincides with SxlPe
activity (2-3hr) was also examined.

Both HOAP and HP1 are associated with SxlPe
The results, as presented in Figure 5.1, indicated an association of HP1 with the SxlPe proximal
region and HOAP with both proximal and distal regions of SxlPe in 1-3hr embryos. Enrichment
of a given Sxl sequence in each ChIP fraction was measured relative to an RpA-70 gene
normalizing standard. A significant 3.5 to 1.9-fold enrichment of sequences in the -101 to +138
region of SxlPe was observed in the HP1 ChIP fraction. Sequence from this region was also
significantly enriched (~2.5-fold) in the HOAP ChIP fraction. In addition, enrichment of two
distinct distal regions (centered at -1132 and at -2224) of SxlPe was also observed in the HOAP
ChIP fraction. SxlPm sequences were not enriched in either the HOAP or HP1 ChIP fraction at
this time. No Sxl sequence was enriched in the IgG ChIP fraction. I also used an anti-Myc
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antibody to pull down chromatin from the same staged embryos from a stock expressing Myctagged HOAP from its endogenous locus (Gao et al., 2010). The results were similar,
corroborating the specificity of the anti-HOAP antibody in immunoprecipitating Sxl sequences
(Figure 5.2 D).

The ChIP results of 4-18hr embryos in Figure 5.2 C, showed that neither HOAP nor HP1 is
associated with the SxlPe proximal sequences after the time of its activity. However, a significant
enrichment of SxlPm proximal sequences was observed in the HP1 ChIP fraction at a time when
SxlPm is active.

The ChIP results for the 2-3hr embryos (Figure 5.2 B) showed a similar association of HOAP and
HP1 with the +138 region of SxlPe at the time of SxlPe activity. However, enrichment of the -101
region was significantly decreased in the HP1 ChIP fraction at this time. The association of
HOAP with the -101 and -1132 sequences was reduced but still measured as significant at this
time. Neither HOAP nor HP1 was associated with SxlPm at this stage also.

RNAP II association with SxlPe is dependent on HP1
The RT-PCR, genetic and in situ hybridization data indicate an activating role for HP1 at SxlPe.
To further elucidate the mechanism of this activating role, I examined the effect of a maternal
Su(var)205 mutation on RNA Polymerase II (RNAP II) association with SxlPe. Chromatin was
prepared from embryos collected from a cross between Su(var)2055/CyO females and Sxl7B0/Y
males at a time when SxlPe is active (2-3hr). Embryos from this cross were used in this
experiment because an almost complete female-lethal phenotype was observed in the adult
progeny. The hypothesis is that the female-lethal phenotype from this cross is a consequence of a
requirement for HP1 to either recruit RNAP II or facilitate transcription elongation. Embryos
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from a cross between wild type females and male Sxl7B0/Y males at the same developmental stage
were used in the control for these experiments. I used three antibodies that recognize specific
isoforms of RNAP II that differ with respect to phosphorylation of its C-terminal domain (CTD).
Unphosphorylated CTD associates with the initiation complex at the promoter; the Ser5- and
Ser2-phosphorylated forms of the CTD heptapeptide repeat associate with the early and late
phases of transcription elongation, respectively (Komarnitsky et al., 2000). These experiments
will allow us to differentiate between the two hypotheses for the role of HP1 in transcription
activation.

The results, as summarized in Figure 5.3, showed that the unphosphorylated and Ser5phosphorylated forms of RNAP II are associated with both SxlPe proximal sequences (-101 and
+138 fragment) in embryos from wild type mothers. In embryos from Su(var)205 mutant
mothers, the association of these two forms of RNA PolII with SxlPe was completely abolished,
regardless of the state of phosphorylation. In contrast, the association of these two
phosphorylated isoforms of RNA PolII with the hunchback promoter, which is also active at this
time in development, was not affected by the Su(var)205 mutation.

Association of HP1 with SxlPe is dependent on HOAP
The strictly maternal effect of Su(var)205 mutations on viability of female progeny and complete
rescue of this female lethality by simultaneous introduction of the cav2248 mutation suggested
antagonistic roles for the maternally supplied HOAP and HP1 in regulating SxlPe prior to the time
of zygotic expression of their genes. This is supported by the in situ hybridization assays
showing SxlPe-derived transcripts to be de-repressed in embryos from cav2248 parents but reduced
in embryos from Su(var)205 parents. Rescue of the Su(var)205 maternal effect by the HP1binding-defective cav1 allele, however, suggested a cooperative activity for HOAP and HP1 in
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repressing SxlPe. This cooperativity could involve a requirement for the partner protein for
binding by the other to SxlPe. To determine whether the associations of HP1 and HOAP with
SxlPe are dependent on each other, I used antibodies against HP1 and HOAP in ChIP assays of
mutants for their protein partner at 1-3hr of development, the time at which both proteins are
enriched in the SxlPe proximal region. The results of the ChIP assays of embryos from
Su(var)2055 mutants (Figure 5.4) showed that HP1 association with SxlPe proximal sequences was
significantly reduced (P < 0.05), but the association of HOAP with these sequences was only
slightly decreased and not measured as significant (0.1 > p > 0.05). The results of the ChIP
assays of embryos from cav2248 heterozygous parents (Figure 5.4), by contrast, showed that the
association of both HP1 and HOAP with SxlPe proximal sequences was almost completely and
significantly reduced. HOAP association with the SxlPe -1132 distal sequence was also
significantly reduced.

Role of histone modifications in regulating SxlPe
Finally, because the repressing role of HP1 might be associated with MeK9H3, as it provides a
binding site for HP1 in heterochromatin-induced silencing, I also used ChIP assays to monitor
this histone modification at SxlPe. The activating role of HP1 could involve a failure to methylate
K4 on histone H3, because it marks active promoters and permits binding of the basal
transcription factor TFIID in recruitment of RNA PolII to promoters (Vermeulen et al., 2007). I,
therefore, examined the parental effect of Su(var)205 and cav mutations on those histone
modifications at SxlPe relative to wild type using ChIP assays. The results in Figure 5.5 showed
that there was no enrichment of SxlPe sequence relative to the simultaneously active hunchback
promoter in embryos from wt parents. However, there was a significant increase in SxlPe
proximal sequence enrichment in the di- and tri-MeK9H3 ChIP fractions from both cav2248
mutants and Su(var)2055 mutants. The association of tri-MeK3H4 with SxlPe relative to the
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hunchback promoter, was also significantly reduced in Su(var)2055 mutants, but was unaffected
in embryos from the cav2248/+ parents.

Discussion
The lethal phenotype of female progeny, from the cross between Su(var)205 mothers and Sxl
fathers, whether or not they carried the Su(var)205 mutation, and only when the Su(var)205
mutation was contributed by the mothers, suggested an early role for maternal HP1 in regulating
Sxl activity. This female lethality was completely rescued by the introduction of the cav2248
mutation into the Su(var)205 mothers, indicating an antagonistic role of HOAP and HP1 in
regulating Sxl activity. These results were supported by the in situ hybridization assays, which
pointed to a repressing role of HOAP and activating role of HP1 on SxlPe transcription. In
addition, defects in SxlPe transcription were observed in a high proportion (>85%) of embryos
from either cav2248 or Su(var)205 heterozygous parents. These results prompted me to apply
ChIP assays to determine if either protein is associated with Sxl sequences in embryos at the time
of SxlPe transcription. Although it is not possible to sort embryos of this stage by sex, ChIP
assays of unsexed embryos can still provide information about whether HOAP and HP1 are
directly associated with SxlPe.

The ChIP results for wild type embryos at 1-3hr, 2-3hr and 4-18hr suggested a correlation
between the association of HP1 with SxlPe and the timing of SxlPe activity. HP1 is enriched in
proximal SxlPe sequences before and during the time of SxlPe activity. The association of both
HP1 and HOAP with SxlPe was completely abolished when SxlPe becomes silent later in
embryogenesis. Moreover, the RNAP II ChIP results showed the enrichment of SxlPe in Un-CTD
and Ser5-CTD PolII ChIP fractions to be significantly reduced in embryos from a cross between
Su(var)205 mutant mothers and Sxl fathers, which results in almost complete female lethality.
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This further supports the requirement for HP1 in transcription activation and suggests a role for it
in the initiation rather than elongation phase of transcription.

The genetic assays and in situ hybridization assays, suggest that HOAP functions as a repressor of
Sxl activity by directly binding SxlPe sequences. HOAP alone also binds to distal sequences of
SxlPe suggesting an HP1-independent activity for HOAP from this region. Furthermore, the ChIP
assays for the embryos from cav and Su(var)205 heterozygous parents showed a significant
reduction in the association of HP1 with SxlPe in cav2248 mutant parents. A smaller, but
insignificant, reduction in the association of HOAP with SxlPe was also observed in Su(var)205
mutant parents. These results indicate a dependence of HP1 on HOAP for its association with
SxlPe and a possible stabilizing effect of HP1 on HOAP in its association.

Neither di- nor tri-MeK9H3 is associated with SxlPe before and during SxlPe activity in wild type
embryos, indicating that this modification is not required for HP1 association at SxlPe. This is
consistent with the genetic data showing the MeK9H3-binding-defective Su(var)2052 allele does
not have a maternal effect on viability of female progeny that are deficient for one copy of Sxl.
The significant increase of the di- and tri-MeK9H3 at SxlPe in the two mutants relative to wild
type could result from a feedback mechanism to compensate for the loss of HP1 or reflect an
indirect global effect of the Su(var)205 mutation on spreading of MeH3K9 modifications into
euchromatic regions that was previously reported by Reuter et al. (2005). It could even indicate a
role for the HOAP/HP1 complex in preventing SU(VAR)3-9 K9-H3 methyltransferase activity at
SxlPe in wild type embryos.

Copyright © Hui Li 2011
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Figure 5.1. HOAP and HP1 are associated with the proximal and distal regions of SxlPe in
the 1-3 hr wt embryos. Fold enrichment of specific Sxl sequence relative to the RpA-70
sequence (Y axis) in the HOAP- (red solid line) and HP1- (green dotted line) ChIP fractions is
plotted along the Drosophila genome (GBrowse) (Tweedie et al., 2009) coordinates for the Sxl
locus (X axis). Black boxes mark the positions of each PCR fragment examined by real time
quantitative PCR. Position of the consensus binding sites for both X-linked transcription
activators (+ E boxes) and autosomal repressors (-E-boxes) are shown (Jinks et al., 2003). The
position of SxlPe and SxlPm –derived transcripts are shown beneath their corresponding sequence in
the molecular map. Significance of enrichment (* = p < 0.05).
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A)

B)

C)

D)

1-3 hr

Figure 5.2. Developmental profile of the association of HOAP and HP1 with SxlPe. Bar
graphs represent fold-enrichment of SxlPe sequences (+138, -101, -1132, -5094, -5331) in HP1(blue bars) and HOAP- (red bars) ChIP fractions relative to the input after normalization against
that for the RpA-70 standard in A) 1-3 hr, B) 2-3hr and C) 4-18hr wild type embryos. D) Bar
graphs represent fold-enrichment of Sxl sequences (+138, -101, -5094, -5331) in HP1- (blue bars)
and Myc- (red bars) ChIP fractions relative to the input after normalization against that for the
RpA-70 sequence standard in 1-3 hr embryos from N-MycHOAP transgenic parents. For each
ChIP, at least two replicates were done. The standard errors between replicates are represented
by error bars. Significance of enrichment (* = p < 0.05, ** = p < 0.01); Significance of difference
from 1-3hr wt (# = p < 0.05, ## = p < 0.01)
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Figure 5.3. RNAP II association with SxlPe was completely abolished in embryos from
Su(var)2055 mothers and Sxl7BO/Y fathers. Bars graphs represent fold-enrichment of (+138)
and (-101) SxlPe and hunchback (hb) proximal promoter sequences in the unphosphorylated
RNAPII (blue bar), Ser2-phosphorylated form of RNAP II (red bar) and Ser5-phosphorylated
RNAP II (green bar) ChIP fractions relative to the input after normalization against the RpA-70
standard. For each ChIP, at least two replicates were done. The standard errors between
replicates are represented by error bars. Significance of enrichment (* = p < 0.05, ** = p < 0.01);
Significance of difference from wt (# = p < 0.05, ## = p < 0.01).
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A)

B)

Figure 5.4. HP1 association with SxlPe is dependent on HOAP, whereas HOAP association
with SxlPe is only moderately affected in mutants for HP1. Bar graphs represent foldenrichment of SxlPe sequences (+138, -101, -1132, -5094, -5331) in HP1- (blue bars) and HOAP(red bars) ChIP fractions relative to the input after normalization against that for the RpA-70
standard in chromatin from: A) Su(var)2055 heterozygous parents and B) cav2248 heterozygous
parents. For each ChIP, at least two replicates were done. The standard errors between replicates
are represented by error bars. Significance of enrichment (* = p < 0.05, ** = p < 0.01);
Significance of difference from wt (# = p < 0.05, ## = p < 0.01)
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Figure 5.5. Both di- and tri-MeH3K9 modifications are increased at SxlPe in embryos from
cav2248 or Su(var)2055 heterozygous parents; tri-MeH3K4 is also decreased at SxlPe in
Su(var)2055 mutant. Bar graphs represent enrichment of SxlPe -101 sequence in tri-MeH3K4(blue bar), di-MeH3K9- (red bar) and tri-MeH3K9- (green bar) ChIP fractions in chromatin from:
wt, cav2248 heterozygous and Su(var)2055 heterozygous parents. Enrichment of SxlPe sequence is
relative to the hb promoter sequence. For each ChIP, at least two replicates were done. The
standard errors between replicates are represented by error bars. Significance of enrichment (* =
p < 0.05, ** = p < 0.01); Significance of difference from wt (# = p < 0.05, ## = p < 0.01)
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Chapter Six
Other Roles for HOAP in Sex Determination

In addition to the maternal role for HOAP in regulating SxlPe, the cav RNAi expression data
indicate zygotic requirements for it in male viability. The male lethal phenotype of loss of
function mutants for HP1 and the HP1-interacting SU(VAR)3-7 protein is associated with
delocalization of dosage component proteins on a shortened and bloated X-chromosome in males
(Spierer et al., 2005). Therefore, a role for HOAP in the sex determination process is addressed
in this chapter. A role for HOAP in male-specific gene expression could also underlie this
zygotic requirement for HOAP in male viability. RT-PCR assays of testis-specific genes that had
reduced transcript levels in the cav1 expression profiling study will also be used to determine if
under-representation of males in the cav1 RNA sample is the sole cause of the reduced transcripts
levels.

HOAP in dosage compensation
To compensate for the presence of only one X chromosome in males and two in females,
Drosophila males hyper-activate gene expression on their single X chromosome by altering the
chromatin of the X chromosome to make it more open to the transcription machinery through a
process involving histone acetylation and non-coding RNA (Gorman and Baker, 1994). This
process is mediated by the Dosage Compensation Complex (DCC), which is made up of proteins
from six male-specific lethal genes [maleless (mle), male-specific lethal-1 (msl-1), male-specific
lethal-2 (msl-2), male-specific lethal-3 (msl-3), male-absent on the first (mof) histone
acetyltrasferase and JIL-1 kinase] and two non-coding RNAs from the X-linked roX1 and roX2
genes (roX = RNA on the X) (Gorman and Baker, 1994) (Franke and Baker, 2000). Dosage
Compensation is achieved by the binding of the DCC to hundreds of sites along the male X
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chromosome. Accordingly, histone H4 acetylated at lysine 14 (H4Ac16), a marker for
transcriptionally active chromatin, is enriched at these sites in males (Bone et al., 1994). The core
component of the DCC is MSL-2, which directs other non-sex-specific components to the X
chromosome. In females, translation of the msl-2 transcript is repressed by SXL protein to
prevent dosage compensation (Bashaw and Baker, 1997) (Kelley et al., 1997). Decreased levels
of MSL-2 reduce the number of binding sites of the DCC on the X chromosome and cause male
specific lethality (Demakova et al., 2003). Over-expression of MSL-1 or MSL-2 causes delocalization of the DCC to binding sites on the autosomes and the chromocenter and female
specific lethality (Demakova et al., 2003).

The male lethal phenotype of loss of function mutants for HP1 or the HP1-interacting
SU(VAR)3-7 protein is associated with a shortened and bloated X-chromosome phenotype in
males, similar to the phenotype observed with over-expression of MSL-2 (Spierer et al., 2005).
This phenotype is suppressed by a mutation in mle, the gene encoding the RNA helicase
component of the DCC (Spierer et al., 2005). Spierer et al. (2008) (Spierer et al., 2008) showed
decreased levels of maternal SU(VAR)3-7 reduced expression of a white reporter gene, an Xlinked gene that is dosage compensated when inserted as a transgene onto an autosome. MSL-1
and MSL-2 were also delocalized away from the X chromosome to the chromocenter in Su(var)37 mutants. Zygotic loss of both copies of Su(var)205 produces a similar phenotype. These
phenotypes are similar to the effects of over-expressing msl-2 (Demakova et al., 2003). Animals
over-expressing SU(VAR)3-7 had a hyper-condensed X chromosome phenotype, and MSL-1 and
MSL-2 were delocalized to autosomal sites, similar to what is observed in loss of function
mutants for roX-1, roX-2 or MSL-2 (Oh et al., 2003). These results suggest an antagonistic
relationship between heterochromatin and dosage compensation proteins on the X chromosome,
and the male lethality for Su(var)3-7 mutants is a result of a loss of balance between these
antagonistic activities in dosage compensation.

63

These results suggested that the enhanced lethality of cav mutant males could result from failure
to properly antagonize this process, as has been observed for both HP1 and SU(VAR)3-7. The
data presented in earlier chapters are consistent with de-repression of SxlPe in the cav mutant
males being responsible for inappropriately preventing expression of dosage compensation in
males. Therefore, the following two hypotheses will be tested: 1) An antagonistic role of HOAP
in dosage compensation process causing MSL-2 redistribution from a bloated X chromosome to
the chromocenter; 2) Down-regulation of MSL-2 through effects of HOAP on SxlPe resulting in
loss of MSL-2 from a hyper-condensed X chromosome to the autosomes.

Results
In an attempt to determine whether loss of HOAP causes an effect that is more similar to that of
the Su(var)3-7 mutant, which resembles MSL-2 over-expression, or more similar to loss of MSL2, as predicted to occur with de-repression of SxlPe, I examined MSL-2 immunostaining on
polytene chromosomes from salivary glands of male cav1 third-instar larvae (Figure 6.1). We
found the salivary glands from cav1 male larvae to be very small and difficult to squash, making it
difficult to identify each chromosome in the spreads. I did not observe the X chromosome to be
either shortened or bloated in the cav1 mutant. MSL-2 appeared to be properly associated with a
single chromosome, which we presumed to be the X chromosome, in some squashes from cav1
mutant males. Reduced MSL-2 staining on this chromosome was, however, observed in the
majority (67%) of chromosome spreads. However, given the difficulty with obtaining good
chromosome spreads from the cav1 mutant, this reduced staining could be a technical artifact.

As a second assay for determining whether HOAP antagonizes dosage compensation or is
required to express DCC components, we hypothesized that introducing a loss of function
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mutation for one of the DCC components into the cav2248 mutant should exacerbate its male
lethality. Over-expressing MSL-2, by contrast, should partially restore male viability.
The results in Table 6.1, show that introduction of a loss of function msl-21 mutation (Zhou et al.,
1995) slightly enhanced the male lethality of cav2248 mutant, but this effect was not significant (p
> 0.05). To over-express MSL-2, a transgene for msl-2 carrying mutations in the SXL-binding
sites in its 5’ and 3’ UTR, making it immune to translational repression by SXL (Kelley et al.,
1997), was introduced into animals expressing cav interference RNA and the ratio of male to
female progeny examined. This transgene (NOPU) is capable of rescuing the male lethality of
msl-2 mutants and one copy of it in females does not result in female-specific lethality (Kelley et
al., 1997). As shown in Table 6.2, the introduction of the MSL-2 transgene rescued male
viability in comparison to the control sibling males lacking it (Z = 2.3, p < 0.05). However, the
poor survival of all sibling control animals expressing cav RNAi makes these results difficult to
interpret. Furthermore, the ratio of males to females (1:2.2) in the cav-RNAi-expressing animals
containing the MSL-2 (NOPU) transgene is not significantly different from that in the absence of
it (Z = 0.6, p > 0.05).

HOAP in sex-specific gene expression
Another possible sex-specific zygotic role for HOAP that could underlie the zygotic effect of
expressing cav RNAi on male viability could be one of regulating male-specific (including testisspecific) gene expression. To determine whether the enrichment of testis-specific genes in the set
of genes with reduced transcript levels in the expression profiling study reflects a direct
requirement for HOAP in testis-specific gene expression rather than an indirect effect of males
being under-represented, I applied semi-quantitative RT-PCR assays to a subset of testis-specific
genes with altered expression in the microarray study to RNA from individually sexed male and
female cav1 larvae.
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Using the RpA-70 gene as normalizing standard, the RT-PCR assays (Figure 6.2) showed the
transcript levels of three out of four testis-specific genes with reduced levels in the expression
profiling study also had reduced levels in individually sexed cav1 male larvae; transcript levels
from CG2082 did not appear to be reduced in the cav1 male RNA. In contrast, transcript levels of
all four non-testis-specific genes were unchanged in cav1 males relative to wt males. RT-PCR
assays of three non-testis-specific genes that had elevated levels in the cav1 expression profiling
study were also used to monitor levels of these transcripts in both male and female cav1 mutant
larvae, relative to wt males and females (Figure 6.3). Only one of the three genes appeared to
have increased transcript levels in cav1 females (CG5550) or males (CG5778), relative to wt
females or males.

Discussion
The MSL-2 immunostaining results shown in Figure 6.1 appeared to show normal distribution of
MSL-2 in cav1 mutant males. However, it only represented ~1/3 of the polytene chromosome
squashes being examined. The other ~2/3 had no staining, which could simply reflect the poor
quality of chromosome spreads from cav1 mutant larvae. It is, therefore, not possible to draw
firm conclusions from these experiments.

The genetic assay shown in Table 6.1 indicated that the introduction of the msl-21 mutation into
cav2248 progeny through their mothers only slightly rescued viability of the male progeny. I was
unable to cross cav2248/TM3 mothers to msl-21/CyO; cav2248/TM3 fathers because males carrying
both mutations (cav2248 and msl-21) did not survive, which may indicate that the msl-21 and cav2248
mutations have a synergistic effect on male viability. The results of the crosses with the
transgene for MSL-2 (NOPU) are even more difficult to interpret. The poor survival of the
sibling control animals expressing cav RNAi, but lacking the MSL2 transgene, complicates the
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interpretation. MSL-2 Western blotting could provide an alternative approach to determining the
effect of the cav mutation on MSL-2 expression, as predicted to occur with inappropriate
activation of SxlPe. Larger effects are expected to be observed in mutant cav male embryos, rather
than mutant cav larvae. However, my method of sexing cav1 embryos requires a PCR assay of
purified nucleic acids, thus, destroying the proteins.

The semi-quantitative RT-PCR assays showed a select group of testis-specific genes with reduced
expression in the microarray study to also have reduced transcript levels in the individually sexed
cav1 male larvae. In contrast, expression of a select group of non-testis-specific genes with
increased transcript levels in the microarray study was not affected in the sexed male cav1 larvae
(Figure 6.2 & 6.3). The magnitude of change in their transcript levels for these selected genes did
not completely match what was observed in the microarray study, suggesting a more quantitative
assay, such as real time quantitative RT-PCR, may be needed. Therefore, the large bias towards
testis-specific genes in the set of genes with reduced transcript levels may reflect a sex
transformation of male gonad, in addition to under-representation of males in the cav1 mutant
larvae. Both effects could occur as a result of SxlPe mis-regulation. Mutations in Sxl and other
genes in the sex determination pathway in the male soma are known to induce sex
transformations in the gonad (Janzer and Steinmann-Zwicky, 2001). To address this possibility, I
will use the male germline marker-1-lacZ (mgm-1-lacZ) enhancer trap line that is expressed
specifically in male germ cells to test the male identity of the gonadal cells in cav1 mutant males
(Janzer and Steinmann-Zwicky, 2001). I will also use the ovo-lacZ reporter for female germline
cells to test the female identity of these cells (Niki and Mahowald, 2003).

Copyright © Hui Li 2011

67

Figure 6.1. MSL-2 displayed normal distribution in polytene chromosomes from male cav1
mutants. The top panel shows DAPI staining (DAPI), MSL-2 immunostaining (MSL-2), and
overlay of DAPI and MSL-2 immunostaining of polytene chromosomes from cav1/TM6Tb male
larvae. The bottom panel shows DAPI staining (DAPI), MSL-2 immun0staining (MSL-2), and
overlay of DAPI and MSL-2 immunostaining of polytene chromosomes from cav1/cav1 male
larvae.
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A) Testis-specific genes identified in the
cav1 microarray
Gene
Log2 P
Expression
name
R
value
Pattern
CG2082
-2.77 0.02
Testis
CG32459 -4.84 0.049
Testis
CG4669
-5.29 0.006
Testis
CG8701
-7.77 0.032
Testis
CG8914
-9.27 0.002
Testis

B) Non-testis-specific genes identified in the cav1
microarray
Gene name
Log2 P
Expression
R
value
Pattern
CG6173/kal-1 -10.8 0.025 Head/fat body
CG4180
-6.78 0.006 Multiple
CG3054
2.2
0.006 Multiple
SOCS36E
2.37
0.031 Multiple/rare
CG11149
10.32 0.008 Midgut

Figure 6.2. Testis-specific genes with reduced transcript levels remain affected in sexed
male cav1 larvae. Semi-quantitative RT-PCR assays of a subset of: A) testis-specific genes with
decreased (log2R < -2.0) transcript levels or B) non-testis-specific genes with increased (log2R >
2.0) transcript levels in the microarray study using a 10-fold dilution series of RNA from wt and
individually sexed male cav1 larvae. The RpA-70 gene serves as the normalizing standard.
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Non-testis-specific genes with elevated transcript levels in the expression profiling study
Gene name
Log2R
P value
Expression Pattern
CG5550
9.83
0.006
midgut
CG5791
48.67
0.048
rare
CG5778
19.63
0.037
rare

Figure 6.3. Non-testis-specific genes with increased transcript levels do not remain affected
in sexed cav1 larvae. Semi-quantitative RT-PCR assays of a subset of non-testis-specific genes
with increased (log2R > 2.0) transcript levels in the microarray study using a 10-fold dilution
series of RNA from wt and cav1 male larvae and wt and cav1 female larvae. The RpA-70
(RPA70) gene serves as the normalizing standard.
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Table 6.1. Introduction of an msl-21 loss-of-function allele slightly exacerbated the reduced
male viability of cav2248 heterozygotes.
♀ cav2248/TM3 X ♂ msl-21/CyO; Lyr/TM3
Progeny
1

2248

msl-2 /+; cav

2248

CyO/+; cav
1

/TM3

2248

msl-2 /+; cav

/TM3

/Lyr

CyO/+; cav2248/Lyr
1

msl-2 /+; Lyr/TM3
CyO/+; Lyr/TM3

Sex

Total

♀:♂

♀

114

1.41 : 1

♂
♀

81
81

1.33 : 1

♂
♀
♂
♀

61
147
96
118

♂
♀
♂
♀
♂

94
158
133
127
120

1.53 : 1
1.26 : 1
1.19 : 1
1.06 : 1

The ratio of ♀ : ♂ for cav2248/TM3 in the presence (1.41:1) or the absence (1.33:1) of msl-21 is
not significantly different (Z=0.149, p > 0.05). The ratio of ♀ : ♂ for cav2248/Lyr in the presence
(1.53:1) or the absence (1.26:1) of msl-21 is not significantly different either (Z=0.947, p > 0.05).
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Table 6.2. Over-expression of MSL-2 rescued the lethality of males expressing cav
interference RNA, although the viability of all sibling control animals was also affected.
♀ Act5C-Gal4/CyO X ♂ UAS-cav-RNAiF8/CyO; P[MSL-2]/TM3
Progeny
Sex
Total
♀:♂
Act5C-GAL4/UAS-cav-RNAiF8; P[MSL-2]/+
♀
103
2.19 : 1*
Act5C-GAL4/UAS-cav-RNAiF8; TM3/+
UAS-cav-RNAiF8/CyO; P[MSL-2]/+
Act5C-Gal4/CyO; P[MSL-2]/+
UAS-cav-RNAiF8/CyO; TM3/+
Act5C-Gal4/CyO; TM3/+

♂
♀

47
15

♂
♀
♂
♀
♂
♀
♂
♀
♂

0
92
97
96
99
32
30
0
0

0
0.95 : 1
0.97 : 1
1.07: 1
0

The ratio of ♀ : ♂ for Act5C-GAL4/UAS-cav-RNAiF8 in the presence (2.19:1) or the absence
(15:0) of P[MSL-2] is significantly different (Z=2.263, p < 0.05). The ratio of ♀ : ♂ for Act5CGAL4/UAS-cav-RNAiF8 in the presence (2.19:1) or the absence (2.49:1) (Table 2.2) of P[MSL2] is not significantly different (Z=0.572, p > 0.05).
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Chapter Seven
Sex-specific Roles for Other HP1- and HOAP-interacting Proteins

Introduction
Chapter 5 showed that association of RNAP II with SxlPe was completely abolished in the
Su(var)205 mutant background, suggesting a positive role of HP1 in RNAP II recruitment or
stability at SxlPe. This activity might involve homologues of two S. pombe proteins that regulate
the repressive and activating activities of Swi6 (HP1) in heterochromatin, Epe1 (Umbrea) and
Chp1 (CG11033). In addition, a role for HOAP in testis-specific gene expression could involve
another HOAP-interacting protein encoded by the testis-specific CG14011 gene.

Epe1 is a K9-H3 de-methylase in S. pombe that has been shown to be recruited to
heterochromatic loci by the HP1 homolog Swi6 to promote RNAP II binding to heterochromatic
repeats (Zofall and Grewal, 2006). Epe1 competes with the chromodomain protein Chp1 for
association with Swi6; Epe1 activates transcription of these repeats, whereas Chp1 represses
transcription. The Drosophila Umbrea gene encodes a chromo shadow domain protein that was
identified in a high-throughput genome-wide yeast two-hybrid screen of Drosophila gene
products (Giot et al., 2003) and later shown to interact with HOAP and HP1 at telomeres and
have a telomere fusion phenotype when knocked down by interference RNA (Joppich et al.,
2009). I, therefore, tested the effect of knocking down Umbrea or CG11033 on sex-specific
viability.

In addition, I did similar assays with RNAi-knockdown and targeted knock out of the CG14011
gene, whose product was also identified as a HOAP-interacting protein in the genome-wide yeast
two-hybrid assay (Giot et al., 2003) and has testis-specific expression. I hypothesized that
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HOAP and CG14011 may cooperate in the testes to activate testis-specific genes, whereas HOAP
and HP1 cooperate in non-testis tissues to silence these genes.

Determining the role of the Epe1 homolog-CG11033 product
To determine if the Epe1-like CG11033 plays a role in the activation of SxlPe by HP1, I first used
the GAL4/UAS binary system to drive the ubiquitous expression of a UAS-CG11033 interference
RNA transgene generated by the Vienna Drosophila RNAi Center (Dietzl et al., 2007). Using the
Act5C-GAL4 driver to express CG11033 RNAi, a ~2 fold reduction in male viability was
observed only in the progeny carrying both the GAL4 driver and CG11033 RNAi transgene
(Table 7.1A). Early zygotic expression of CG11033 RNAi though the nullo-GAL4 driver caused
a similar ~2 fold reduction in male viability only in animals carrying both transgenes (Table
7.1B). No sex-specific lethality was observed when CG11033 RNAi was driven by the germlinespecific nanos-GAL4 either paternally or maternally and crossed to wild type animals (Table
7.1C & D). A cross between mothers carrying both the nanos-GAL4 driver and CG11033 RNAi
to Sxl/Y fathers also did not result in any sex-specific lethality (Table 7.1E). Therefore, the
effects on male viability seen only with expression of CG11033 RNAi through the Act5C- and
nullo-GAL4 drivers appears to be a completely zygotic one and are likely to occur after the time
of SxlPe activation in the early embryo.

Determine the role of Umbrea
To determine if Umbrea is required for sex-specific viability, I used the strong ubiquitous Act5CGAL4 driver to express a UAS-Umbrea RNAi transgene generated by the Vienna Drosophila
RNAi Center (Dietzl et al., 2007) and observed a lethal phenotype for both males and females,
only in animals carrying both the GAL4 driver and UAS-Umbrea RNAi transgene (Table 7.2A).
Expression of Umbrea interference RNA in the female germ-line through a nanos-GAL4 driver
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reduced viability of male progeny (Table 7.2 D). Interestingly, the reverse phenotype was
observed when mothers of this genotype were crossed to Sxl mutant father; female viability was
reduced (Table 7.2E). In contrast, paternal expression of Umbrea interference RNA by nanosGAL4 driver had no effect on sex-specific or sex non-specific viability (Table 7.2C). Embryonic
expression of Umbrea interference RNA through the nullo-GAL4 driver also did not show either
male or female lethality (Table 7.2B). These results point to an early requirement for Umbrea in
sex-specific viability that resembles that of HP1.

Determining the role of the testes-specific CG14011 HOAP-interacting protein
Ubiquitous expression of a UAS-transgene for CG14011 interference RNA generated by the
Vienna Drosophila RNAi Center (Dietzl et al., 2007) by the Act5C-GAL4 driver did not reduce
either male or female viability (Table 7.3A). I also used ends-in targeted recombination
technology to make a knock-out mutation in CG14011. I observed no reduction in either male or
female progeny in this presumed knockout mutant for CG14011 (CG14011KO). I also combined
this mutation with the cav2248 mutation to examine it for genetic interaction with cav. The results
in Table 7.3, showed that introduction of one copy of CG14011KO allele into cav2248 fathers
rescued the viability of male progeny only carrying the cav2248 mutation, in comparison to their
viability in the cross of Table 2.4C, in the absence of the CG14011KO allele (Z = 3.659, n >312,
p < 0.01). Viability of male progeny carrying both the CG14011KO and cav2248 alleles, in
comparison to their siblings lacking CG14011KO, was reduced, but not to significant levels (Z =
1.415, n >137, p > 0.05). It should also be noted that knockout of CG14011 in this stock has not
been confirmed by PCR.
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Discussion
The genetic assays described in this chapter attempted to examine the interaction of cav with
CG14011 and determined the sex-specific viability phenotypes of knocking down CG11033 and
Umbrea. RNAi knockdown of CG11033 produced a zygotic male lethal phenotype that is
presumably not related to SxlPe activity. The Umbrea RNAi knockdown phenotype was most
consistent with an early requirement for Umbrea for sex-specific viability that is similar to that of
HP1. Therefore, if the knockdown of Umbrea is specific to it, and does not also affect
Su(var)205 as an off-target, these phenotypes suggest a role for it in SxlPe regulation. The
targeted recombination knock-out allele for CG14011 also appeared to rescue the cav2248 paternal
effect (Z = 3.659, n >312, p < 0.01). It will, however, be necessary to confirm knockout of the
CG14011 gene in this allele through PCR assays.

Copyright © Hui Li 2011
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Table 7.1. Effects of CG11033 inteference RNA expression on sex-specific viability.
A)

♀ Act5C-GAL4/CyO X ♂ UAS-CG11033-RNAi (2)
Progeny
Total
♀:♂
Act5C-GAL4/UAS-CG11033-RNAi
♀
119
2.16 : 1*1
♂
55
CyO/UAS-CG11033-RNAi /+
♀
98
0.87 : 1
♂
113
B)

♀ nullo-GAL4 (2) x ♂ UAS-CG11033-RNAi (2)
Progeny
Total
nullo-GAL4/UAS-CG11033-RNAi
♀
99
♂
44
C)
Progeny
♀ total
♂ total
D)
Progeny
♀ total
♂ total
E)
Progeny
♀ total
♂ total

♀:♂
2.25 : 1*2

♀ yw x ♂ nanos-GAL4/UAS-CG11033-RNAi/+
Number
94
101

♀:♂
0.93 : 1

♀ nanos-GAL4/UAS-CG11033-RNAi x ♂ yw
Number
73
63

♀:♂
1.16 : 1

♀ nanos-GAL4/UAS-CG11033-RNAi/+ x ♂ Sxl7BO/Y
Number
♀:♂
194
1.11 : 1
174

Viability of male progeny was reduced by expression of CG11033 interference RNA through the:
A) ubiquitous Act5C-GAL4 driver (*1: Z = 4.2, n >174, p < 0.01) or the B) embryonic nulloGAL4 driver (*2: Z = 4.1, n >143, p < 0.01). Sex-specific viability was not affected when the
germline-specific nanos-GAL4 driver was used to drive expression of CG11033 in: C) males
crossed to wild type females, D) females crosses to wild type males, or E) females crossed to Sxl/Y males.

77

Table 7.2. Effects of Umbrea inteference RNA expression on sex-specific viability.
A)
♀ Act5C-GAL4/CyO X ♂ UAS-Umbrea-RNAi/TM3
Progeny
Total
Act5C-GAL4/+; UAS-Umbrea-RNAi /+
♀
0
♂
♀
♂
♀
♂
♀
♂

CyO/+; UAS-Umbrea-RNAi /+
Act5C-GAL4/+; TM3/+
CyO/+; UAS-Umbrea-RNAi/+

0
150
112
24
38
0
0

♀:♂
0
1.34 : 1
0.63 : 1
0

B)
♀ nullo-GAL4 (2) x ♂ UAS-Umbrea-RNAi/TM3
Progeny
Sex
Number
nullo-GAL4/+; Umbrea-RNAi/+
♀
36
♂
38
nullo-GAL4/+; TM3/+
♀
43
♂
35
C)
♀ yw x ♂ nanos-GAL4/+; UAS-Umbrea-RNAi/+
Progeny
Number
♀ Total
62
♂ Total
69

♀:♂
0.95:1
1.23:1

♀:♂
0.90 : 1

D)
Progeny
♀ Total
♂ Total

♀ nanos-GAL4/+; UAS-Umbrea-RNAi/+ x ♂ yw
Number
105
37

♀:♂
2.84 : 1*1

E)
Progeny
♀ Total
♂ Total

♀ nanos-GAL4/+; UAS-Umbrea-RNAi/+ x ♂ Sxl7BO/Y
Number
48
105

♀:♂
1 : 2.19*2

Crosses were used to determine the effect of Umbrea interference (Umbrea RNAi) expression on
sex-specific viability when driven by the A) ubiquitous Act5C-GAL4 driver, B) embryonic nulloGAL4 driver, and the nanos-GAL4 driver in C) males crossed to wild type females, D) females
crossed to wild type males (*1: Z = 4.0, n >142, p < 0.01), and E) females crossed to Sxl7BO/Y
males (*2: Z = 3.1, n >153, p < 0.05).
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Table 7.3. Genetic assays to determine the role of CG14011 in sex-specific lethality.
A)
♀ Act5C-GAL4/CyO X ♂ UAS-CG14011-RNAi (3)
Progeny
Total
Act5C-GAL4/+; UAS-CG14011-RNAi /+
♀
136
♂
♀
♂

CyO/+; UAS-CG14011-RNAi /+

131
125
96

♀:♂
1.04 : 1
1.30 : 1

B)
Progeny
+/+; cav2248/+

♀ cav2248/TM3 X ♂ CG14011KO#2 /+; cav2248/+
Total
♀
77

CG14011KO#2/+; cav

2248

♂
♀
♂
♀
♂
♀
♂

/+

+/TM3 & cav2248/TM3
+/+; TM3/+ & CG14011KO#2/+; TM3/+

81
79
58
141
114
127
132

♀:♂
0.95 : 1
1.36 : 1
1.24 : 1
0.96 : 1

Crosses were used to determine the effect of CG14011 interference (CG14011 RNAi) expression
on sex-specific viability when driven by the A) ubiquitous Act5C-GAL4 driver and B) in a
CG14011 knock-out allele generated by targeted homologous recombination introduced into
cav2248 heterozygous fathers crossed to cav2248 heterozygous mothers.
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Chapter Eight
Final Discussion

Decreased HOAP levels reduce male viability
The enrichment of testis-specific genes in the set of genes with reduced transcript levels in the
cav1 mutant expression profiling study led to genetic experiments showing reduced male viability
in mutants for HOAP. Preferential lethality was observed with expression of cav interference
RNA and for two different cav alleles, cav1 and cav2248. The severity of the male lethal phenotype
in animals expressing cav interference RNA paralleled the severity of endogenous cav mRNA
knockdown. The lethality of both cav1 homogygotes and cav2248 heterozygotes occurred in late
embryogenesis, as the majority of embryos of these genotypes failing to progress to the larval
stage were males. The lethal phase of male cav2248 heterozygotes is late in embryogenesis after
denticle belt formation, whereas cav2248 homozygotes of both sexes die earlier in embryogenesis
with a high frequency of telomere fusions. The dominant male lethal phenotype for cav2248
heterozygotes is presumably the result of a truncated protein, produced from a nonsense mutation
within the sequence for the N-terminal HMG-Box, which appears to have dominant negative
activity. Its effect on male viability is equivalent to that of knocking down cav mRNA to 20% of
wild type levels. The cav1 allele has a frameshift mutation, which results in a C-terminal
truncation of the protein and severely compromises HP1-binding activity. Three hypotheses
were proposed to address the cause of the enhanced male lethality for HOAP mutants: 1) titrating
effect of Y chromosome on heterochromatin proteins; 2) defect in sex determination and/or
dosage compensation; 3) defect in male-specific gene expression required for male viability.
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Presence of heterochromatic Y chromosome is not the cause of reduced male viability
I first tested the hypothesis that the Y chromosome titrates HOAP and other heterochromatin
proteins away from telomeres and other cell vital regions to make males more vulnerable to
mutations in these proteins. The male lethality of mutants for bonus, which encodes the TIF1β
HP1-interacting protein, is dependent upon the presence of the heterochromatic Y chromosome
(Beckstead et al., 2005). The introduction of heterochromatin from other chromosomes also
reduced viability of bonus mutants. However, in the genetic assay in which a compound X-Y
chromosome [C(1;Y)] was introduced into animals expressing cav interference RNA, the Y
chromosome had minimal effect on viability of animals expressing cav RNAi, in comparison to
the significant effect of the animal’s sex.

Defects in sex determination were observed in cav mutants
Next, I tested the hypothesis that the male lethal phenotype of cav mutants involves defects in the
sex determination pathway, specifically in Sxl activity. Sxl, the master regulator of this pathway,
is normally inactive in males and active in females. This insures male-specific expression of the
dosage compensation machinery and appropriate regulation of sexual differentiation genes in
both sexes. As an indicator of the function of this pathway in cav mutants, I used RT-PCR assays
to monitor sex-specific splicing of Sxl transcripts. The presence of aberrant female Sxl transcripts
in male cav1 homozygous and cav2248 heterozygous embryos was observed in these assays.
Genetic assays also indicated that loss of function mutations in Sxl rescue the male lethality of
cav2248 mutants; however additional crosses with genetic markers that are tightly linked to Sxl are
still needed to genotype the male progeny. These assays are underway. Nevertheless, the genetic
and RT-PCR assays pointed to a repressive role of HOAP in regulating SXL activity, which was
then shown through in situ hybridization assays to reflect a role of HOAP in repressing
transcription from the establishment promoter of the gene (SxlPe). SxlPe-derived transcripts were
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inappropriately expressed in male embryos and prematurely expressed in female embryos from
cav2248 heterozygous parents.

In contrast to the repressive role of HOAP in regulating SxlPe, HP1 appears to have both
activating and repressing roles on this promoter. The genetic assay in which female lethality was
observed in progeny from Su(var)205 mothers and Sxl fathers suggested an activating role for
HP1 in Sxl expression. This is consistent with the RT-PCR assays showing male-spliced Sxl
transcripts in Su(var)205 mutant female larvae, as well as female-spliced transcript in males. The
decreased levels of SxlPe-derived transcripts in embryos from Su(var)205 heterozygous parents
also support a requirement for HP1 in activating SxlPe. The ChIP assays showed HP1 to be
associated with the proximal SxlPe region before and during the time of SxlPe activation and HP1
to be required for stable association of RNAP II with SxlPe in this activation. ChIP assays also
showed physical association of HOAP with this proximal region and with two discrete distal
regions of SxlPe at this time (before and during activation).

Interdependent roles for HOAP and HP1 in SxlPe regulation
Both HP1 and HOAP association with the proximal SxlPe region was reduced in mutants for their
partner protein. However, only the reduction in HP1 association in mutants for HOAP was
considered statistically significant. This could indicate a greater reliance of HP1 on HOAP for
binding to SxlPe or reflect the stronger dominant negative activity of the cav2248 mutant allele. In
spite of the dependence of HP1 on HOAP, the genetic data also show antagonistic functions of
the two proteins; introduction of the cav2248 mutation into Su(var)205 mothers completely rescued
the effect of the Su(var)205 mutation on the viability of female progeny having a reduced zygotic
dose of Sxl. A maternal Su(var)205 mutation also rescued the viability of male progeny from
cav2248 heterozygous fathers. Taken together, mutants for HP1 and HOAP have antagonistic
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effects on sex-specific viability and SxlPe activation, yet HP1 is dependent on HOAP for its
association with SxlPe.

Like HOAP, HP1 may also have a repressive activity at SxlPe. Knockdown of HP1 by Su(var)205
interference RNA also causes preferential male lethality (Liu et al., 2005). The aberrant presence
of female-spliced Sxl transcripts in male Su(var)205 mutants suggests a requirement for HP1 in
repressing Sxl expression in males. A repressive role for HP1 at SxlPe is also consistent with the
partial rescue of female viability in progeny from Su(var)205 mutant mothers and Sxl mutant
fathers by introduction of the cav1 allele into these mothers. This allele produces a HOAP
protein that is compromised for HP1-binding (Badugu et al., 2005; Cenci et al., 2003), indicating
that HOAP repression is partly HP1-dependent.

HP1-independent mechanism of HOAP in regulating SxlPe
The presence of HOAP alone in the SxlPe-distal region indicates an HP1-independent role for it in
repressing SxlPe from this region. Estes et al. (Estes et al., 1995) showed 1400 bp upstream of
SxlPe is required for full expression in females, although sequence to -200 bp is sufficient to
provide sex-specific expression. Regulation within the 1400bp region is dependent upon the
antagonistic activities of maternally-loaded and zygotically-expressed transcription factors
encoded by X-linked and autosomal signal elements (XSEs and ASEs) that provide a mechanism
for determining the X to A ratio. XSEs include a bZIP protein, sisterless-a (sis-a) (Erickson and
Cline, 1993) and a beta Helix-Loop-Helix (bHLH) factor, Scute (sis-b) (Torres and Sanchez,
1989) that form heterodimers with maternal bHLH Daughterless protein (Cabrera and Alonso,
1991), which bind positive (+) E box binding sites in the SxlPe regulatory region (Figure 5.1).
The bHLH Deadpan protein (Bier et al., 1992; Younger-Shepherd et al., 1992), the only known
ASE, binds negative (-) E boxes in this region.
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The histone deacetylase activity of a maternal Groucho (Paroush et al., 1994) co-repressor
complex provides a mechanism for decreasing the sensitivity of the SxlPe regulatory region to
minor spurious fluctuations in the doses of positive and negative bHLH heterodimers to ensure a
true readout of the X to A ratio. HOAP and HP1 presumably have similar dampening effects on
SxlPe activation. Their activities in the SxlPe-proximal region are presumably both antagonistic
and cooperative. HOAP and HP1 may cooperatively repress SxlPe from this region. However,
because HOAP alone is associated with the distal SxlPe region, and its association was not
significantly affected in the Su(var)205 mutant, HOAP activity in this region is presumably HP1independent. HOAP binding in the distal region overlaps a cluster of positive E-box binding
sites, but it is absent from the negative E-box binding sites in this region. This suggests that
HOAP may repress SxlPe from this region through competition with positive E-box proteins, but
not negative E-box proteins, for binding to this region. To further address this model in the
future, ChIP assays can be used to determine whether the association of Scute and Deadpan with
SxlPe is affected in the cav2248 mutant embryos and vice versa. These can be combined with
promoter fusion assays of the distal and proximal regions to further explore the regulatory roles
of HOAP and HP1 in each region.

Roles for other proteins in SxlPe regulation
In summary, we propose a model in which HOAP and HP1 form a repressive complex in both
sexes prior to SxlPe activation (Figure 8.1). The genetic data for Umbrea RNAi knockdown
suggest that Umbrea may also play a role in this repressive complex. During activation of SxlPe at
2-3 hr (cycle 12-14), the complex continues to repress in males but switches to activation mode in
females. How HP1 switches to activation mode is an open question. The expression profiles of
mRNA for HOAP and HP1 in early embryos may provide one mechanism for the switch (Figure
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8.2). The abundance of cav mRNA increases sharply just before the activation of SxlPe and then
plummets. In contrast, Su(var)205 mRNA levels are low early in embryogenesis but increase
dramatically at the time of SxlPe activation. These inverse expression patterns at the time of SxlPe
activation could affect this switch by altering the ratio of HOAP to HP1 at SxlPe.

The switch to activation mode might also involve other proteins, such as the Epe1-like CG11033
protein and Chp1-like Umbrea protein. Epe1 is recruited to heterochromatic loci of S. pombe
through Swi6 to de-methylate K9 of histone H3 and facilitate transcription of heterochromatic
repeats (Zofall and Grewal, 2006). This prompted us to determine if CG11033 is involved in
HP1 activation at SxlPe. Expression of RNAi against CG11033, through either the ubiquitous
Act5C-GAL4 driver or early embryonic nullo-GAL4 driver reduced male viability. However, no
effect was observed when nanos-GAL4 was used to drive maternal expression of CG11033
RNAi, suggesting that the effects on male viability in the other crosses were completely zygotic.
The nullo promoter is activate early in embryogenesis (Simpson and Wieschaus, 1990), just
before a peak of CG11033 transcription (Figure 8.2). Therefore, expression of CG11033 RNAi
from the nullo-GAL4 drive could potentially affect SxlPe expression. But the effects of CG11033
RNAi knockdown on male, rather than female, viability are consistent with a repression, rather
than activation, role for it at SxlPe. My ChIP data for di- and tri-MeH3K9 also do not support a
role for this histone modification in regulating SxlPe in wild type embryos. Therefore, the effects
of CG11033 RNAi knockdown are more likely to be indirect, through effects on the pool of HP1
available to bind SxlPe, for example.

I also tested the role of Umbrea, as a Chp2-like activity, in SxlPe regulation. Chp2 is an HP1-like
protein in S. pombe whose dose shifts the equilibrium of S. pombe HP1 (Swi6) activity towards
repression (Zofall and Grewal, 2006). Umbrea is an HP1-like protein that contains a
chromoshadow domain only and interacts with both HOAP and HP1 at telomeres where it is also
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required to prevent telomere fusions (Joppich et al., 2009). Expression of Umbrea interference
RNA from a nanos-GAL4 driver produced an HP1-like phenotype of reducing male viability in a
wild type genetic background, but produced a female-lethal phenotype in a Sxl mutant
background. Therefore, Umbrea may have a role similar to HP1 in the HOAP/HP1 complex at
SxlPe-proximal region prior to the time of SxlPe activation. The peak of Umbrea expression
around the time of SxlPe activation (Figure 8.2) could even be important in switching HP1 from
repression mode to activation mode by perturbing the HOAP/HP1 interaction.

The ChIP assays at SxlPe do not support an unambiguous role for histone modifications in the
activity of HOAP/HP1 at SxlPe in wild type animals. The association of di- and tri- MeK9H3
with SxlPe does, however, become significantly enriched in embryos from mutants for either
Su(var)205 or cav heterozygous parents. This could suggest that the HOAP/HP1 complex is
required to prevent this histone modification at SxlPe in wild type animals. It could also result
from the global spread of these modifications from heterochromatin to euchromatin observed in
Su(var)205 mutations (Schotta et al., 2002). Nevertheless, a greater increase was observed at
SxlPe than at the simultaneously expressed hb promoter, so a parallel role for MeK9H3, and even
the RNAi machinery, is possible.

Finally, phosphorylation of HP1 could play a role in the switch. However, the maternal
expression of transgenes mimicking HP1 phospho-isoforms did not show different levels of
rescue of the female viability phenotype of Su(var)205 mutant mothers. This indicates that
phosphorylation at these PKA sites is not involved in the activity of HP1 at SxlPe or it could
reflect insufficient promoter activity of the pUAST transgenes used in the germ-line. There is
also the possibility that phosphorylation at other sites (e.g. Casein Kinase II) plays a role.
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HOAP in dosage compensation
The enhanced male lethal phenotype is also observed in mutants for HP1 and SU(VAR)3-7 that
has been found to involve a defect in the process of dosage compensation (Spierer et al., 2008;
Spierer et al., 2005) . The DCC is delocalized from the X to the chromocenter in these mutants.
The zygotic requirement for HOAP in my RNAi knockdown experiments could be related to a
defect in this process. On the other hand, de-repression of SxlPe in mutants for HOAP, would
theoretically reduce expression of the crucial component of the DCC (MSL-2), which is a direct
downstream target of SXL activity at the level of translation (Kelley et al., 1997) . Decrease in
MSL-2 expression reduces binding of DCC on the X chromosome; MSL-2 over-expression
causes de-localization throughout the genome (Demakova et al., 2003). MSL-2 immunostaining
of polytene chromosomes from the cav1 mutant, however, showed a normal distribution of MSL2 on the X in some chromosome spreads. De-repression of SxlPe in cav mutants would also be
expected to be enhanced by introduction of a mutation in msl-2 and suppressed by MSL-2 overexpression. The results of these genetic assays (Table 6.1) were difficult to interpret because
complete lethality of males, and females to less extent, was observed in the control animals for
the MSL-2-over-expression experiment. A weak, but insignificant enhancement was observed in
the msl-2 mutant experiment. In summary, the results are inconclusive as to whether mutants for
HOAP have defects in dosage compensation. The results of the MSL2-immunostaining
experiments are also inconclusive. Therefore, a future experiment will be to use MSL-2
immunoblotting of individually sexed cav1 mutant larvae. The male embryos that fail to progress
to the larval stage would be more likely to display defects in MSL-2 expression, but it is not
possible to use the PCR-based method of sexing embryos and also examine them by western
blotting.
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The direct role of HOAP in regulating testis-specific gene expression
Finally, I tested the third hypothesis that a defect in testis-specific gene expression, in addition to
SxlPe de-repression, accounts for the enrichment of testis-specific genes in genes with reduced
transcript levels in the cav1 microarray profiling study. The magnitude of the reduction in these
transcript levels may be too large to be completely explained by an under-representation of males
in cav1 mutant larvae. RT-PCR assays of some of these testis-specific genes showed them to
have reduced transcript levels in the cav1 mutant males that were able to survive to the larval
stage. This result, along with the reduced size of the male gonad in cav1 mutant larvae, may
reflect a sex transformation in the gonad of cav1 males. To address this possibility, I can take
advantage of sex-specific germline reporters (mgm-l-lacZ and ovo-lacZ) to test the sexual identity
of the germ cells in cav1 male larvae. I have constructed the reporter strains needed for a future
member of the lab to use. There is also a possibility that HOAP has a direct role in regulating
testis-specific genes. The HOAP ChIP on chip data on 3L pericentric heterochromatin showed
that HOAP is associated with testis-specific genes, including CG32459, which was downregulated in RT-PCR assays of sex cav1 larvae (Figure 6.2). To address the possibility, a βgalactosidase assay can be applied to promoter fusion assay transgenes for the CG32459 5’flanking sequence in mutants for cav. HOAP ChIP assays can also be used to determine if HOAP
is physically associated with the regulatory regions of other testis-specific genes that had reduced
expression in the RT-PCR assays of male cav1 mutants (Figure 6.2).

Evolutionary relevance of HOAP function in regulating Sxl
The sex-specific gene regulatory role of HOAP is of particular interest in terms of its homology
to the sequence-specific class of HMG boxes found in the mammalian SRY (sex-determining
region Y) protein (Stros et al., 2007), where it is required for activation of testis-specific genes in
the testis and repression of those genes in the ovary (Oh and Lau, 2006; Oh et al., 2005). The
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repressive activity of SRY in the ovary is HP1-dependent (Peng et al., 2009). The inductive
effects of the mammalian gonad on somatic development places SRY high in the hierarchy of the
sex determination pathway in mammals, similar to the position of HOAP in regulating Sxl in
Drosophila sex determination. The dominant negative activity of the cav2248 allele, which
produces a mutant protein that is truncated within the HMG box of HOAP, suggests a role for the
HMG box in its repressive activity at SxlPe. The association of HP1 with SxlPe is also dependent
on this DNA-binding activity. Furthermore, the ChIP data showing association of HOAP with
testis-specific genes could also indicate an activity for it, like SRY, in regulating gene expression
in the testis.

The role of HOAP and HP1 in sex determination is also paralleled in mating type gene regulation
in S. pombe. Swi6, the HP1 homolog, is known to be recruited to the mating type locus and
telomeres through redundant mechanisms of the RNA-induced initiation of transcriptional gene
silencing (RITS) complex and DNA-binding activities (Atf1/Pcr1) (Hall et al., 2002; Jia et al.,
2004; Petrie et al., 2005). SxlPe may similarly be subject to both RNAi-independent and RNAidependent regulatory mechanisms; work in the lab of our collaborator, Jamila Horabin at Florida
State University, shows defects in its regulation in mutants for the RNAi machinery. The
increased levels of di- and tri-MeK9H3 we observed in mutants for HP1 and HOAP could be
related to this.

In spite of the importance of sexual reproduction for eukaryotes, sex determination pathways are
poorly conserved (Vallender and Lahn, 2006); SRY proteins are restricted to non-placental
mammals. The gene for HOAP was first discovered as a fast evolving gene (Schmid and Tautz,
1997); its rate of non-synonomous to synonymous substitutions between Drosophila species
(Schmid et al., 1999) and between D. melanogaster populations (Andolfatto, 2001) is one of the
highest in the D. melanogaster genome. The N-terminal part of the protein, containing the HMG,
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is the most highly conserved domain between various Drosophila species; the central part of the
protein has undergone the most rapid evolution (Schmid et al., 1999) (Figure 8.3). It is possible
that the DNA-binding domain of HOAP has an evolutionary history in testis gene regulation, and
acquisition of an HP1-binding domain in the central and C-terminal region allowed it to take on
new activities at telomeres. A testis-specific regulatory role could also be important for it in
regulation of telomere-specific transposable elements in the germline.

Copyright © Hui Li 2011
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Figure 8.1. Proposed model for regulatory roles of HOAP and HP1 at Sxl gene before and
during SxlPe activity. Before SxlPe activity, HOAP, HP1, and possibly Umbrea, form a
repressive complex at SxlPe proximal regions. The dashed line surrounding the Umbrea oval
conveys the ambiguity of this role. HOAP also binds to SxlPe distal regions. During SxlPe
activity, HP1, and possibly Umbrea, switch to an activator mode to allow association of RNA
Polymerase II to SxlPe only in females.
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Figure 8.2. Developmental expression patterns for cav, Su(var)205, Umbrea and CG11033.
The Log2 Ratio of expression for each gene, relative to the median level of expression of all
genes, is shown on the Y axis in relationship to specific 1 to 2 hour intervals throughout
development indicated along the X axis.
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Figure 8.3. Sequence alignment for HOAP (anon fe 1G5 gene product) in four Drosophila
species. Sequence alignment of anon fe 1G5 gene product from D. melanogaster, D. simulans,
D. yakuba and D. pseudoobscura is shown. Dark shading indicates regions of identity; light
shading indicates regions of similarity.
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Chapter Nine
Materials and Methods

Fly strains and markers
The cav RNAi lines were obtained by germline transformation of the pUAST vector containing
an inverted repeat of a nearly full length cDNA sequence for the cav-RB transcript. The cav1
allele is a loss-of-function allele that has non-sense mutation in the third HP1-interacting domain
(Cenci et al., 2003). The cav2248 allele was recovered in a screen of progeny from ethane methyl
sulfonate (EMS)-mutagenized males which failed to complement the original cav1 allele, and the
sequence of the allele was determined from PCR products obtained from homozygous cav2248
embryos identified through their lack of the homologous twi-GAL4, UAS-GFP marked balancer
chromosome (w1118; DrMio/TM3, P{GAL4-twi.G}2.3, P{UAS-2xEGFP}AH2.3, Sb1 Ser1). The
Su(var)2055 is a null allele caused by deletions (Eissenberg et al., 1992). The Act5C-GAL4 (y1
w*; P{Act5C-GAL4}25FO1/CyO, y+), nullo-GAL4 (y1 w*; P{nullo-GAL4.G}5.20) and nanosGAL4 (y1 w*; P{GAL4-nos.NGT}40) lines are GAL4 drivers described in Flybase (Appendix 1).
Flies in all crosses were reared under uncrowded conditions on standard cornmeal medium
enriched with active dry yeast. Unless otherwise noted, all crosses were done at 25°C; Ore R or
y1w67c23 were used as the wild type control. Progeny were counted for 8 days beginning on the
first day of eclosion. The Z test was used in statistical analyses of distributions in two
populations (Sprinthall, 2003). Description of genes can be found on Flybase
(http://flybase.org/).
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RT-PCR analysis
RNA was similarly prepared from pools of male and female cav2248 heterozygous and cav1
homozygous embryos and from individual Su(var)2054/Su(var)2055 larvae. The cav2248
heterozygous embryos were identified from a pool of tightly staged embryos that failed to
progress to the larval stage and contained intermediate levels of GFP expression from the twiGAL4, UAS-GFP-marked TM3Sb balancer chromosome. The cav1 homozygous embryos were
similarly identified through their lack of GFP expression from this balancer chromosome.
Su(var)2054/Su(var)2055 larvae were identified through their lack of GFP expression from the
Act5C-GAL4-marked CyO balancer chromosome. The sex of individual cav2248 heterozygous
and cav1 homozygous embryos was first determined through PCR of the Y-linked kl-2 gene from
a total nucleic acid extraction from individual embryos. RNA was then purified using Qiagen
RNeasy Mini Kit (Cat. No. 74104), followed by DNase I treatment using Qiagen RNase-Free
DNase Set (Cat. No. 79254) from pools of the nucleic acids extracted from individual male or
female embryos. The sex of individual Su(var)2054/Su(var)2055 larvae was first determined
through the presence or absence of the y+-marker from the paternally derived X chromosome and
then substantiated through PCR assays of the Y-linked kl-2 gene. RNA purified from these pools
was quantified spectrophotometrically. Semi-quantitative RT-PCR assays were carried out with
10ng total RNA template per 50 μl reaction through the Qiagen One-Step RT-PCR kit (Cat. No.
210210). The sequences of all primers used are shown in Appendix 2. Primers for the
Drosophila RpA-70 were used in PCR reactions to determine that all RNA samples were DNAfree before they were used in RT-PCR as a positive control (Appendix 2).

Chromatin Preparation
A modification of the protocol described in (Alekseyenko et al., 2006) was used to prepare crosslinked chromatin from embryonic progeny from parents of the following genotypes: wild type
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(y1w67c23 or yw), yw; cav2248/TM3Sb, yw; Su(var)2055/CyO, yw females x Sxlf1/Y males, and yw;
Su(var)2055/CyO females X Sxlf1/Y males. Embryos from yw parents were collected at the
following developmental stages: 0.75 to 2.75 hr (labeled 1-3 hr), 2-3 hr, and 4-18 hr. Embryos
were collected from yw; Su(var)2055/CyO females crossed to Sxlf1/Y males in parallel to those
from yw females crossed to Sxlf1/Y males (at 2-3 hr stage). Embryos from yw; cav2248/TM3Sb and
from yw; Su(var)2055/CyO parents were also collected in parallel (at 0.75 to 2.75 hr stage). All
embryo collections and staging were done at 22oC. Chromatin was prepared from 6.0 g yw
embryos homogenized in 6.0 ml homogenization buffer [50 mM Hepes at pH 7.6, 60 mM
potassium chloride, 0.25 M sucrose, protease inhibitor cocktail (Huang et al., 1998)]. The
homogenate was clarified by centrifugation at 700 x g for 10 minutes (2000 rpm in SS34) to
remove particulate cellular debris. The nuclear supernatant was removed and 1/10 volume of
10% formaldehyde (freshly prepared from paraformaldehyde) was added. After incubation with
rotation for 15 minutes at RT, Glycine was added to final concentration 0.25M to stop the crosslinking. The cross-linked chromatin was precipitated by centrifugation at ~2000 x g (5000 rpm in
SS-34 rotor) for 10 min at 4oC and then washed 3 times in phosphate buffered saline (150 mM
sodium chloride (NaCl), 10 mM sodium phosphate, pH 7.6) (with centrifugation at 2,000 x g
(5000 rpm in SS-34) for 10 minutes after each wash and re-suspended in 6.0 ml RIPA buffer (50
mM Tris-HCl, pH 7.6, 1 mM ethylene diamine tetraacetic acid (EDTA), 0.5 mM ethylene glycol
tetraacetic acid (EGTA), 140 mM NaCl, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS).
The nuclear fraction was then sonicated in RIPA buffer for 5 X 4 sec bursts on output setting 5
and aliquoted to 500 μl per tube. Glycerol was added to each aliquot to final concentration of 5%
and all aliquots were quickly froze in liquid nitrogen or EtOH/dry ice bath and stored in -70°C.
An average length of 500 bp was determined by agarose gel electrophoresis of an ethanol
precipitate of one aliquot. A scaled down version of the protocol was carried out with 0.5 g
mutant embryos in 1.0 ml homogenization buffer. The homogenate was clarified by
centrifugation at 700 x g (1,000 rpm in microfuge) before adding 1/10th volume formaldehyde as

96

described above. The cross-linked chromatin was then pelleted by centrifugation at 6,000 rpm.
All subsequent wash steps were also done with 6,000 rpm centrifugation. The final volume of the
scaled down sonnicated chromatin fraction was 1.0 ml; this was aliquoted as 200 μl per tube.

Chromatin Immunoprecipitations
Chromatin immunoprecipitations were performed with 500 μl clarified chromatin (200 μl for
scaled down version), 20-40 μg antibody [20 μl anti-HOAP(Shareef et al., 2003), 20 μl antiHP1(#1803) (Huang et al., 1998), anti-RNA polymerase II antibody (Covance MMS-126R,
MMS-134, or MMS-129R), anti-di and tri MeK9 histone H3 (Millipore 05-1249 and 05-1242) or
non-immune IgG (Santa Cruz Biotech. SC-2027 or SC-2025)] in 2.0 ml (1.5 ml in scaled-down
version) RIPA buffer at 4 oC overnight with rotation,100 μl anti-rabbit (Sigma A914) or antimouse (Sigma A6531) IgG agarose were then added to each ChIP fraction at 4 oC for 3 hours with
rotation. Chromatin/agarose was pelleted by centrifugation at 1000 rpm ( x g) for 3 minutes at 4
°C in microcentrifuge. Washes were performed as described in (Alekseyenko et al., 2006). The
immunoprecipitated material was eluted from the beads by incubation at 37°C for 1 hr with
rotation in 500 μL TE (1 mM EDTA, 50 mM Tris, pH 8.0) containing 0.5% sodium dodecyl
sulfate (SDS) and proteinase K (0.1 mg/ml), followed by the addition of NaCl to 0.3 M and SDS
to 1% and rotation at 65°C over night. The samples were then extracted once with
phenol/chloroform, once with chloroform before ethanol precipitation in the presence of glycogen
(20μg per 1ml). The purified ChIP DNA is eluted in 30 μl H2O and input DNA is eluted in 200
μl H2O.
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Protocol for quantitative real-time PCR
The iCycler iQ real-time PCR detection system (Bio Rad) was used to quantitate Sxl sequences in
the precipitated DNA from each ChIP fraction. The primer pairs shown in Appendix 2 were used
to amplify fragments spanning the Sxl locus as shown in Figure. 5.1. RpA-70 was used as the
normalizing standard in most reactions (sequence of primers in Appendix 2). PCR amplification
was performed in duplicate in 50 μL SYBR Green qPCR SuperMix (Bio-Rad Cat. No. 1708882). Dissociation curve analysis was performed at the end of 40 cycles, and quantification was
carried out by Bio-Rad comparative CT methodology with standard curves constructed for each
primer pair with a serial dilution of input DNA having PCR efficiencies of 80-120%.
Enrichment of a given sequence in the ChIP fraction was calculated as ng for ChIP/ ng for input
for the specific Sxl sequence divided by the same for RpA-70 in the same ChIP reaction. The ng
of a sequence in a given sample was determined from a standard curve of a 1:5, 1:10, 1:100, and
1:2,000 dilution of Input DNA of known concentration. To calculate enrichmenet ng in 200 l
ChIP was multiplied by 30, before dividing by the ng in 200 l Input x 200 (to equalize for
different resuspension volumes for ChIP vs. Input after cross-link reversal of similar volumes
(200 l). These enrichment values were then compared to enrichment of a normalizing control
(RpA-70 gene or hb promoter sequence). Enrichment values were also calculated as % input,
using the absolute signal for a given ChIP fraction relative to the standard curve with Input DNA
(without translating to ng DMA). Enrichment determined by this method was not normalized.
Conclusions obtained by the two methods were identical in all cases, except for the methylation
data.
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Statistical Treatment of ChIP data

For each ChIP reaction, at least two biological replicates were done. A one sample t-test
[1 tail, unequal (type 3) variance] was performed to identify sequences that were enriched
in ChIP fractions above background (i.e., > 1); a student’s t test was used to determine
significance of differences between two samples of equal variance [2 tails, equal (type 2)
variance].

Copyright © Hui Li 2011
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Appendices
Appendix 1. List of fly stocks and markers used in this study.
Common Name
twi-GAL4, UAS-GFP
marked balancer
Act5C-GAL4
nullo-GAL4
nanos-GAL4
Sxlf1
UAS-CG11033-RNAi
UAS-Umbrea-RNAi

Proper Name
w1118; DrMio/TM3, P{GAL4-twi.G}2.3,
P{UAS-2xEGFP}AH2.3, Sb1 Ser1
y1 w*; P{Act5C-GAL4}25FO1/CyO, y+
y1 w*; P{nullo-GAL4.G}5.20
y1 w*; P{GAL4-nos.NGT}40
y1 cm1 Sxlf1 v1 f1/FM7a/Dp(1;2;Y)w+
CG11033 RNAi (VDRC) on 2nd homoz viable
CG15636 RNAi (VDRC) /TM3Sb on 3

100

Stock Number
BL-6663
BL-4414
BL-26875
BL-4442
BL-3708
VDRC-109295
VDRC-13072

Appendix 2: Results of cav1 microarray study (Log2R > 2.0 or < -2.0).
Affy TagDrosophila
Genome 1

log 2 R

Gene
Name

p value

cDNA Library
Representation

Chintapalli
et al.
tissue/adult
enrichment

embryo

none

Parisi et al.
testes/ovary
enrichment

Compiled
Expression
Data

Genes with Reduced Transcript Levels
145319_at

-2.08

0.003

phm

N/A

embryo

148103_at

-69.61

0.004

dro5

multiple

141293_at

-33.65

0.009

CG9362

multiple

multiple

N/A

multiple

multiple

N/A

141440_at

-14.13

0.01

b

multiple

multiple

N/A

multiple
multiple

153219_at

-12.12

0.004

CG7768

multiple

multiple

N/A

multiple

143559_at

-7.91

0.008

ple

multiple

multiple

N/A

multiple

143970_at

-7.34

0.002

Clk

multiple

multiple

N/A

multiple

144311_at

-6.78

0.006

CG4180

multiple

multiple

N/A

multiple

142188_at

-5.9

0.003

Pif1b

multiple

multiple

N/A

multiple

152004_at

-5.52

0.009

eya

multiple

multiple

N/A

multiple

143403_at

-5.55

0.006

vg

multiple

N/A

multiple

149054_at

-5.01

0.006

CG9452

rare

multiple
multiplelow

N/A

multiple

155099_at

-4.30

0.003

bib

multiple

multiple

N/A

multiple

153488_at

-3.45

0.001

heph

multiple

multiple

N/A

multiple

152034_at

-3.34

0.008

CG10139

multiple

multiple

N/A

multiple

152265_at

-3.30

0.008

CG11892

multiple

N/A

multiple

150844_at

-3.19

0.009

CG12068

multiple

multiple
multiplelow

N/A

multiple

155062_at

-3.18

0.01

BEAF-32

multiple

multiple

N/A

multiple

149779_at

-3.12

0.004

CG18549

multiple

multiple

N/A

multiple

143268_at

-3.09

0.01

mnd

multiple

multiple

N/A

multiple

144536_at

-3.01

0

Tre1

multiple

multiple

N/A

multiple

145677_at

-3

0.007

CG3117

rare

multiple

N/A

multiple

154844_at

-2.79

0.009

cdc2

multiple

multiple

N/A

multiple

143464_f_at

-2.78

0.008

LysB

multiple

N/A

N/A

multiple

144734_at

-2.71

0.002

CG12115

multiple

multiple

N/A

multiple

153480_at

-2.69

0.009

Map60

multiple

multiple

N/A

multiple

141388_at

-2.64

0.009

dap

multiple

multiple

N/A

multiple

150195_at

-2.64

0.01

CG5316

multiple

multiple

N/A

multiple

146874_at

-2.47

0.003

CG2063

multiple

multiple

N/A

multiple

145098_at

-2.43

0.007

Lsd-2

multiple

multiple

N/A

multiple

142578_at

-2.28

0.002

pr-set7

multiple

multiple

N/A

multiple

154656_at

-2.15

0.009

Aos1

multiple

multiple

N/A

multiple

153930_at

-2.13

0.008

CG5224

multiple

multiple

N/A

multiple

153243_at

-2.11

0.002

lwr

multiple

multiple

N/A

multiple

151082_at

-2.08

0.008

CG33111

multiple

testis (6.8x)

multiple

143679_at

-2.06

0.005

spn-A

multiple

N/A

ovary

149186_at

-2.28

0.005

Mkrn1

multiple

N/A

ovary

143834_at

-2.26

0.008

CycB3

multiple

N/A

ovary

141239_at

-2.22

0.009

ovo

rare

multiple
ovary
(1.8x)
ovary
(2.3x)
ovary
(2.3x)
ovary
(2.9x)

ovary

ovary

141337_at

-53.44

0.006

CG7906

rare

eye (113x)

N/A

rare

143465_f_at

-11.52

0.006

LysC

rare

N/A

N/A

rare
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145643_at

-8.16

0.001

CG31684

rare

145734_at

-4.84

0.002

CG2816

rare

152219_at

-22.03

0.006

CG6304

testis (57%)

148801_at

-20.31

0.009

CG7804

testis

149981_at

-19.92

0.003

CG4546

testis (46%)

145909_at

-18.45

0.007

CG11043

testis

152703_at

-17.93

0.003

CG7848

testis (60%)

142968_at

-17.84

0.01

CG9279

testis (58%)

144854_at

-17.03

0.001

CG15200

testis

142673_at

-14.42

0

CG8292

testis

150757_at

-14.12

0.009

CG5017

testis

147290_at

-13.97

0.01

CG3687

testis

152992_at

-13.46

0.007

CG10934

testis (50%)

146671_at

-13.39

0

CG14589

rare

152628_at

-12.86

0.004

CG1999

rare

142331_i_at

-12.63

0.002

CG3875

testis

144514_at

-12.32

0.009

TrxT

N/A

150334_at

-11.69

0.004

CG31178

testis

146743_at

-11.67

0.005

CG11125

testis

151006_at

-11.26

0.006

CG15219

testis (71%)

147441_at

-11.05

0.001

CG17669

testis

148940_at

-10.82

0.003

CG13725

testis

151765_at

-10.43

0.007

CG31624

testis

146412_at

-10.2

0.009

CG7094

testis

144885_at

-9.74

0.01

CG11697

testis

149928_at

-9.71

0.01

RpL10Aa

testis

144120_at

-9.27

0.002

CkIIbeta2

143393_at

-9.26

0.01

betaTub85D

146804_at

-9.19

0.009

146302_at

-9.14

0.006

147634_at

-9.03

0

150197_at

-8.76

0.008

153056_at

-8.29

0.009

146241_at

-8.26

152333_at

-8.17

147684_f_at

-7.89

147518_at

none
multiplelow

N/A

rare

N/A

rare

testis (9.9x)
testis
(14.8x)
testis
(10.0x)
testis
(10.3x)
testis
(12.2x)

testis(29.7x)

testis

N/A

testis

testis (10.8x)

testis

testis (6.4x)

testis

testis (11.0x)

testis

testis (6.5x)
testis
(10.4x)
testis
(15.3x)

testis (37.2x)

testis

testis (23.0x)

testis

testis (16.1x)

testis

testis (8.9x)
testis
(12.5x)
testis
(13.9x)
testis
(10.2x)
testis
(10.4x)
testis
(14.2x)

testis (19.3x)

testis

testis (9.0x)

testis

N/A

testis

testis (5.1x)

testis

testis (16.2x)

testis

N/A

testis

testis (6.3x)
testis
(10.4x)
testis
(11.9x)
testis (3.4
x)
testis
(14.4x)
testis
(10.2x)

testis (19.9x)

testis

testis (47.3x)

testis

testis (10.8x)

testis

testis (4.5x)

testis

testis (5.9x)

testis

testis (9.7x)

testis

testis (4.4x)
testis
(13.2x)
testis
(13.8x)

testis (34.6x)

testis

testis (8.0x)

testis

testis (8.3x)

testis

testis (34.7x)

testis

testis

testis (9.2x)
testis
(13.1x)

testis (16.0x)

testis

testis (77%)

testis (5.6x)

testis (33.5)

testis

CG18449

testis

testis (31.2)

testis

ACXA

testis

testis (6.9x)

testis

Grx-1

testis

testis (6.0x)
testis
(20.1x)
testis
(14.6x)

testis (7.2x)

testis

CG3517

testis (90%)

testis (8.3x)

testis (34.0x)

testis

ssp5

testis (98%)

testis (9.7x)

testis (58.8x)

testis

0.008

CG14926

testis (79%)

testis (4.8x)

testis (43.2x)

testis

0.002

sm

testis (50%)

testis (29.6x)

testis

0.004

CG3927

testis

testis (7.1x)
testis
(13.6x)

testis (5.9x)

testis

-7.56

0.01

CG8517

testis

testis (6.8x)

testis (22.3x)

testis

151443_at

-7.5

0.004

CG13245

testis (71%)

testis (5.7x)

N/A

testis

144286_at

-7.36

0.008

CG4218

testis

testis

N/A

testis
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(10.8x)
151906_at

-7.33

0.004

CG5538

testis (73%)

testis (8.1x)

testis (39.1x)

testis

145981_at

-7.1

0.001

CG7196

testis

testis (12.9)

testis (12.9x)

testis

143686_at

-7.06

0.001

Arp53D

testis

testis (14.2)

N/A

testis

143432_at

-6.81

0.01

Mst98Cb

N/A

testis (90.5x)

testis

146857_at

-6.8

0.001

CG13747

testis

testis (7.2x)
testis
(10.1x)

testis (4.7x)

testis

146552_at

-6.79

0.008

CG33322

testis

testis (16.6)

N/A

testis

144488_at

-6.78

0.009

CG7024

testis

testis (9.8x)

testis (12.6x)

testis

143434_at

-6.74

0.01

Mst84Dd

testis

testis (4.2x)

testis (63.9x)

testis

151334_at

-6.71

0.004

CR32658

testis

testis (16.2x)

testis

150336_at

-6.63

0.003

CG17819

testis (67%)

N/A

testis

145709_at

-6.4

0.009

CG8840

testis

testis (13.0x)

testis

145439_at

-6.23

0.009

hydra

testis

N/A

testis

149662_at

-6.22

0.001

CG6629

testis

testis (29.9x)

testis

145156_at

-6.11

0.006

CG8565

N/A

testis (40.2x)

testis

150454_at

-6.1

0.005

CG10164

testis

N/A

testis

149978_at

-6.08

0.006

CG14876

testis

N/A

testis

146777_at

-6.03

0.001

CG30378

testis

N/A

testis

145607_at

-5.92

0.005

CG7295

testis

N/A
testis
(15.5x)
testis
(10.6x)
testis
(10.2x)
testis
(10.9x)
testis
(11.8x)
testis
(11.0x)
testis
(12.8x)
testis
(10.8x)
testis
(14.3x)

testis (8.3x)

testis

141371_at

-5.78

0

CG13263

testis

N/A

testis

152084_at

-5.7

0.003

sut4

testis

N/A

testis

152092_at

-5.4

0.005

CG4323

testis

testis (28.0x)

testis

146081_at

-5.39

0.003

CG13110

testis

testis (8.3x)
testis
(11.9x)
testis
(11.9x)
testis
(12.1x)

testis (11.0x)

testis

153027_at

-5.29

0.006

CG4669

testis (88%)

testis (7.8x)

testis (56.4x)

testis

145978_at

-5.23

0.007

CG7211

testis

N/A

testis

143795_at

-5.22

0.001

Ssl

testis

N/A

testis

152391_at

-4.89

0.001

CG1340

testis (78%)

testis (9.4x)
testis
(11.6x)
testis
(16.4x)

N/A

testis

152731_at

-4.79

0.009

CG8838

testis

testis (34.1)

testis

151140_at

-4.74

0.005

CG30222

testis

testis (8.9x)
testis
(10.6x)

testis(12.8x)

testis

146805_at

-4.72

0.005

CG2127

testis

testis (106x)

testis

145464_at

-4.62

0.003

CG14579

testis

testis (3.0x)

testis

148475_at

-4.55

0.008

CG3222

testis

testis (3.8x)
testis
(16.3x)
testis
(10.9x)

testis (23.9x)

testis

151971_at

-4.51

0.006

CG11060

testis

N/A

testis

148765_at

-4.33

0.008

CG13471

testis

testis (8.1x)
testis
(12.5x)

N/A

testis

152645_at

-4.32

0.006

CG7742

testis

testis (9.7x)

testis (21.6x)

testis

144447_at

-4.27

0.009

CG13021

testis

testis (5.0x)

N/A

testis

143274_at

-4.27

0.003

Mst87F

testis

testis (2.6x)

testis (49.1x)

testis

151454_at

-4.2

0.003

CG12167

testis

N/A

testis

CG10177

testis

testis (4.3x)
testis
(17.2x)

testis (37.5x)

testis

Dhc36C

testis

testis (9.5x)

testis (4.1x)

testis

150449_at

-4.2

0

143725_at

-4.06

0.004
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142792_at

-4.04

0.007

CG11386

rare

152890_at

-3.72

0.007

CG10126

testis

144811_at

-3.65

0.003

CG15296

testis

150362_at

-3.65

0.001

CG13855

testis

147932_at

-3.58

0

Ppm1

testis

151537_at

-3.55

0.008

CG33278

testis

147858_at

-3.52

0.003

CG3494

testis

146608_at

-3.33

0.003

CG10834

rare

150618_at

-3.27

0.001

CG17770

testis

152716_at

-3.24

0.01

CG3492

149430_at

-3.16

0.008

CG1288

145315_at

-3.09

0.01

147667_at

-3.01

150038_at

testis
(14.5x)

N/A

testis

N/A

testis

testis (6.9x)

testis

N/A

testis

testis (10.0x)

testis

N/A

testis

testis (18.6x)

testis

N/A

testis

testis (23.1x)

testis

testis

testis (4.5x)
testis
(10.8x)
testis
(11.7x)
testis
(12.5x)
testis
(19.1x)
testis
(10.2x)
testis
(17.9x)
testis
(12.9x)
testis
(11.0x)

testis (22.5x)

testis

testis

N/A

testis (33.6x)

testis

CG15040

rare

N/A

testis

0.008

CG11291

testis

N/A

testis

-2.72

0.005

CG14909

rare

testis (5.7x)

testis

148908_at

-2.7

0.009

CG13032

testis

N/A

testis

146602_at

-2.59

0.004

CG1421

N/A

testis (3.6x)

testis

146245_at

-2.48

0.004

CG14930

testis

N/A

testis

142311_at

-2.41

0.005

Ubc84D

testis

testis (9.1x)
testis
(14.1x)
testis
(12.0x)
testis
(13.0x)
testis
(14.5x)
testis
(15.1x)
testis
(12.7x)

testis (13.8x)

testis

149858_at

-2.13

0.006

CG9602

testis

testis (10.4x)

testis

154179_at

-6.01

0.005

CG8478

multiple

N/A

testis/ovary

149176_at

-4.32

0.001

E(bx)

testis

N/A

testis/ovary

147842_at

-2.57

0.004

spag

testis

N/A

testis/ovary

153420_at

-2.54

0.007

Neos

multiple

N/A

testis/ovary

141299_at

-2.03

0.009

CG12104

embryo

testis (9.8x)
testis, ovary
(2.8x)
testis, ovary
(2.0x)
testis, ovary
(2.0x)
testis, ovary
(2.0x)
testis, ovary
(3.0x)

N/A

testis/ovary

N/A

carcass

N/A

midgut

N/A

midgut

N/A

midgut

N/A

midgut

N/A

midgut

N/A

midgut

N/A

midgut

Genes with Elevated Transcript Levels
151237_at

8.17

0.006

CG13230

none

142147_at

3.01

0.009

CG9466

multiple

141389_at

6.85

0.009

Cht9

ubiq

144327_at

8.48

0.002

CG7631

rare

147334_at

9.83

0.006

CG5550

rare

143695_at

10.25

0.004

pcl

rare

145842_at

10.32

0.008

CG11149

rare

142359_at

15.42

0.004

CG30360

rare

147598_at

21.43

0.005

Cht4

rare

carcass
midgut
(7.5x)
midgut
(20.0x)
midgut
(12.5x)
midgut
(12.5x)
midgut
(17.5x)
midgut
(20.0x)
midgut
(15.6x)
midgut
(11.5x)

N/A

midgut

147498_at

2.09

0

CalpA

multiple

multiple

N/A

multiple

151429_at

2.11

0.001

CG14933

multiple

multiple

N/A

multiple
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153172_at

2.18

0.008

CG31886

multiple

multiple

N/A

multiple

152413_at

2.2

0.006

l(2)k05819

multiple

multiple

N/A

multiple

147171_at

2.31

0.007

CG6337

multiple

multiple

N/A

multiple

154652_at

2.32

0.006

alpha-Est1

multiple

multiple

N/A

multiple

149632_at

2.51

0.006

Cyp12e1

multiple

multiple

N/A

multiple

149722_at

3.07

0.008

CG18547

rare

multiple

N/A

multiple

144407_at

2.54

0.003

CG8310

rare

multiple

N/A

multiple

145813_at

2.64

0.008

Cyp28d2

multiple

multiple

N/A

multiple

141351_at

2.8

0.007

kst

multiple

multiple

N/A

multiple

152848_at

2.85

0.001

CG1698

multiple

multiple

N/A

multiple

147607_at

3.02

0.007

Glycogenin

multiple

multiple

N/A

multiple

142254_at

3.18

0.007

CG10562

multiple

multiple

N/A

multiple

154737_at

3.31

0

Ndg

multiple

multiple

N/A

multiple

153087_at

3.57

0.008

CG8654

multiple

multiple

N/A

multiple

142969_at

3.82

0.005

Cys

multiple

multiple

N/A

multiple

144364_at

4.32

0.01

CG14630

multiple

multiple

N/A

multiple

152083_at

4.45

0.006

CG15093

multiple

multiple

N/A

multiple

149937_at

4.55

0.005

CG6912

multiple

multiple

N/A

multiple

152779_at

6.19

0.004

CG8774

multiple

multiple

N/A

multiple

149964_at

6.35

0.01

CG14872

rare

multiple

N/A

multiple

142746_at

6.77

0.003

Men

multiple

multiple

N/A

multiple

145897_at

18.05

0.001

CG42369

multiple

N/A

multiple

149889_at

2.05

0.005

CG3259

rare

multiple
multiplelow

N/A

rare

145058_at

2.65

0.004

CG1461

none

N/A

rare

153504_at

3.23

0.009

CG33137

none

N/A

rare

147127_s_at

3.56

0.002

CG13323

rare

N/A

rare

150252_at

4.27

0

CG4362

rare

multiple
multiplelow
multiplelow
multiplelow

N/A

rare

154595_at

4.65

0.002

CG7526

rare

multiple

N/A

rare

147126_i_at

5.63

0.001

CG13323

rare

N/A

rare

148709_at

5.88

0.002

CG14105

rare

multiple
multiplelow

N/A

rare
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Appendix 3. Primer sequences used in RT-PCR and real-time PCR for ChIP assays.
PCR frag in Fig. 5.1
+7101F
+7101R
+1218F
+1218R
+138F
+138R
-101F
-101R
-432F
-432R
-918F
-918R
-1132F
-1132R
-1394F
-1394R
-1810F
-1810R
-2224F
-2224R
-2647F
-2647R
-3488F
-3488R
-5094F
-5094R
-5331F
-5331R
Sxl RT-PCR:
SxlP1F
SxlP2F
SxlP3R
Control primers:
RpA-70F
RpA-70R
hbF
hbR
kl-2F
kl-2R
Sxl in situs
SxlPeF
Sxl PeR
SxlPmF
SxlPmR

Sequence
CAGCTCGCGATCGGTCATGT
CGGCGGAAATGGTGGGAGTG
GCCAAAGAGGTATGGGTAGC
GTGGTTATCCCCCATATGGC
CGCTTATCCAGGGTTGCCATACCA
CGGCACCCCTCTGTCGATCC
GTCCTGCGGGCCATCGATCT
CGGGGATCCGCGAAATGCAG
GCCGAAAGGTGGAACGTGGC
GTATTGTGCTGGTATTGCTTC
TTTTGCTAGGATTTCGGGTAG
CTGTTCTTGGCGTTCGATTAG
CTAATCGAACGCCAAGAACAG
CTAGGGCTTAGGGCTCACTGG
TTCCAGTGAGCCCTAAGCCCTAGCC
TAGGCCGCCCCACCCACTTG
GCTGGAATGGGGTGGTACGG
CCCCAAAAGTTTTGTCCGTGATGGAC
GTCCATCACGGACAAAACTTTTGGGG
AGAACACACATTCACTCAAGCACTGC
GATGCATGTACACATCTGTGC
ATATGTTTCGGTTCCGCAATG
GAAGCGAACATCTTCCCTTGC
CGACCGCCCTACGTCGACGGC
ACACGGATTGCATGGGGCACA
TGACCGACAACCGCGAAACGTG
CACGTTTCGCGGTTGTCGGTCA
TGAACGAAATCTAACGGGGCTCAAAAGAC

GadFly Coordinates
6979712-6979731
6979916-6979897
6985512-6985531
6985743-6985724
6986594-6986617
6986960-6986941
6986915-6986934
6987117-6987098
6987225-6987244
6987469-6987449
6987721-6987741
6987944-6987924
6987924-6987944
6988169-6988149
6988147-6988171
6988463-6988444
6988510-6988529
6988940-6988915
6988915-6988940
6989362-6989337
6989424-6989444
6989719-6989699
6990249-6990269
6990558-6990538
6991909-6991929
6992109-6992088
6992088-6992109
6992404-6992376

CACCGCTGCCCAGCGACAAT
TTGCGTTTCGTTGGCGAGGACC
GAGCGCTGAGCGCCAAAACAATTGA

6979801-6979820
6982643-6982662
6985955-6985931

CACCGCCGAGGCTCAAGGAC
TGCAAGGAGGTGGGCGAGTTG
GCCTGTCAATGCTGGCGACTTTCG
GAAAGAGCGAACGCCACGAAGGG
GGTTGCCCAATGTGAGTGAAGCGTC
TCGCTTAGCTCGCCGCCGTA

4088834-4088853
4089056-4089036
4523493-4523516
4523867-4523845
82313-82337
82775-82756

GTTTCTAAGCAGATCCCG
GTTCCACTCGTGACAAGTCC
GGGCGATGCTTGCATGTTGC
GCGAAACGTGCACACTGC

6986495-6986512
6986902-6986883
6991059-6991078
6992097-6992080
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